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CHAPTER 1 INTRODUCTION AND OVERVIEW OF ATHEROSCLEROSIS AND ATHEROSCLEROTIC DISEASE MODELS
Blood vessels are the component of the cardiovascular system that transports
blood throughout the human body. In the cardiovascular system, there are three major
types of blood vessels arteries, veins, and capillaries. Arteries carry blood away from the
heart whether it is to lungs via the Pulmonary Artery or throughout the body via the Aorta
and other major arteries. Veins carry blood towards the heart by ways of the Pulmonary
Vein or the Vena Cava and other major veins. Capillaries allow for the actual exchange
of water and nutrients between the blood and tissues. How this exchange can take place
is dependent on the structure of the vessel.
Arteries and veins are composed of three main layers the tunica intima, tunica
media, and tunics adventitia. The tunica intima layer is a monolayer of endothelial cells
(ECs), inside the lumen of the vessel that allows for nutrient and gas diffusion. Tunica
media layer is, the middle component, made of vascular smooth muscle (SMCs), which
controls the tone of the vessel. This layer is thicker in arteries due to the high pressures
associated with distributing the blood to tissue all over the body. The tunica adventitia
layer, the outer component, is mostly composed of connective tissue which is comprised
of collagen and vascular fibroblasts. Capillaries on the other hand are only comprised of
endothelial cells that also form a tubular monolayer about 10 microns in the diameter.
This allows for individual erythrocytes to pass through and deliver oxygen to the tissues
and take up carbon dioxide. Also, this enables nutrients and waste products to passively
diffuse through tissue. But in the case of atherosclerosis, obstruction of blood flow can
impede this process causing tissue damage.
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Atherosclerosis
Atherosclerosis is a disease where in which plaque builds up inside of arteries.
The plaque is made up of cholesterol, fat, calcium, and other compounds found in blood.
This process begins with the ratio of low density lipoprotein (LDL) and high density lipoprotein (HDL) in the blood stream (Davis et al., 2005). When the LDL concentration increases, the likelihood of atherosclerosis increases. Normally LDL then binds to the LDL
receptors on the ECs stimulating endocytosis of the particles. When concentration of LDL
increases, not enough receptors on the ECs are available to trigger endocytosis. Excess
LDL then becomes trapped in the sub-endothelial space between the tunica intima and
media. This creates oxidative stress on the ECs causing the release of O22- from inside
the cells. The O22- binds to the LDL forming ox-LDL. During this time P-selectin and vascular cell adhesion molecule 1 (VCAM-1) on the ECs recruit monocytes. Monocytes bind
to the P-selectin receptors along the surface of ECs in rolling migration until they bind to
VCAM-1 signaling them to stop the rolling migration (Libby et al., 2002). Monocyte chemoattractant protein 1 (MCP-1) binds to chemokine ligand 2 (CCL-2) signaling monocyte
migration into the sub-endothelial space (Fig. 1-1A). Monocytes differentiate into macrophages later engulfing the ox-LDL particles. Macrophages then differentiate into foam
cells which give off specific chemical signals activating T-cells. T-cells then give off signals amplifying the inflammation response repeating the process. ECs begin to secrete
fibroblast growth factor and while foam cells secrete PDGF, stimulating SMC proliferation
and migration around the foam cells. SMCs then secrete collagen, leading to the creation
of a fibrous cap (Fig. 1-1B). Calcification occurs soon after due to the SMCs secreting
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calcium locally around the fibrous cap. This is observed as plaque on the inside of arteries.

Monocyte
Endothelial Cell

B
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Smooth Muscle Cell
Figure 1-1. Diagram of inflammation process leading to atherosclerosis of an artery (Libby et al., 2002).

Over time this causes arteries to become hardened and stiff, affecting the compliancy of the vessel. This obstructs the flow of blood to regions of the body afflicted with
this disease. Due to the plaque the flow of the vascular system will become turbulent
changing the biomechanics of the region. Atherosclerosis can lead to myocardial infarctions, heart failure, poor blood perfusion to extremities and even death. To understand
more about this disease, in vivo and in vitro models have been created.
Atherosclerosis Models
In Vivo Models
Animals are wildly used in research for testing of new treatments as well as modeling of specific diseases. In the case of atherosclerosis, the disease varies from species
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to species based upon their advantages and limitations (Getz et al., 2012). Animals used
for atherosclerosis models can be broken down in two groups: mice and large animal
models. Mice models have a relatively low cost. Also, genetic manipulations are easily
performed, and atherosclerosis develops over a short period. On the other hand, their
small size poses issues, they have limited complexity of lesions and their bodies at times
may be resistant to atherosclerosis.
Large animal models such as pigs, rabbits and non-human primates may also be
used to model the disease. Pigs are sensitive to atherosclerosis on a normal diet, contain
humanoid lesions including coronaries, and have similar lipoprotein classes except for
HDL types. Limitations include their price, no genetic modifications available and narrow
genetic models (low gene variation per animal). Rabbits however are the more cholesterol
sensitive animal model. But their lesions are largely foam cells and they have prudent
number of genetic modifications. Non-human primates have humanoid lipoproteins and
lesions, also they can develop coronary lesions. On the other hand, primates are one of
the most expensive animal models, they have no genetic modifications, and contain limited genetic manipulation (Getz et al., 2012). To cut cost on animal care and maintenance
researchers could switch to possible in-vitro disease models.
In Vitro Models
Common in vitro models used to model atherosclerosis include cadaver arteries,
porcine arteries, and 2D cell culture. A study using six healthy and six diseased cadaver
arteries tested the use of a contact probe catheter for laser angioplasty (Geschwind et
al., 1987). The cadaver arteries embedded were embedded in agar to further simulate
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human tissue. Normally, cadavers are perfused with formaldehyde as a means of preservation, which in turn alter the physical characteristics of the arteries, while killing the cells
at the same time. Another study utilized de-cellularized porcine arteries as a scaffold and
re-perfused the tissue with human umbilical vein endothelial cells (HUVECs) and myofibroblasts (Robert et al., 2013). Using LDL and HDL, they attempted to develop atherosclerosis with aid monocytes present in the model. The limitation of this model is the fact
that their vessel does not have a tunica media layer. Due to this, they observed monocytes in the sub-endothelial space, but no fibrous cap formation or calcification was found
in the system. A study looking at the modeling of carotid artery atherosclerosis used endothelial cells in a specialized perfusion system (Estrada et al., 2011). This system was
designed to simulate normal and disturbed flow as seen in blood flow inside the human
body. They measured pressure, flow and shear stressing of the system, which was limited
to Cartesian model. Also, the group only focused on ECs instead of co-culturing with
SMCs to achieve fatty, calcified plaque build-up. Despite these different modeling techniques there is still a need for a tissue engineered model not relying on another species
for vessel construction.
Tissue Engineering
With the popularity of creating three-dimensional tissues engineered for therapeutic value, interests have widened to utilizing them for disease modeling (Mahmoodian et
al., 2015). One study considered modeling a normal and diseased kidney in vitro (Subramanian et al., 2010). They seeded mouse embryonic kidney epithelial cells onto a silk
scaffold. The experiments were performed via a perfusion bioreactor to replicate the phys-
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iological processes in vitro. Another study used three-dimensional engineered heart tissues to model human heart diseases (Ralphe et al., 2013). They used these engineered
tissues to evaluate the force production of the tissue under various genetic phenotypes.
The creation of engineered vessels to analyze diseased and normal physiological states
increases the knowledge on illnesses affecting the region. Tissue engineered vessel using human cells will provide a means to evaluate atherosclerosis as if it is occurring in
humans. But, in order to do this a simple and quick method for developing engineered
tissues must be available.
The Ring Stacking Method
Creating ring stacks of each cell layer is a stable method to create vascular tissue
due to the additive strength increase of each individual segment. This idea for creating
blood vessels in vitro is based on a concept taken from segmented roadway tunnels,
where the interaction between the rings and its segments enhances its structural integrity
(Galván et al., 2013). Each piece is constructed individually, followed by joining of the
robust singular components to construct the final secure structure. Segment joining is
also seen in 3D CT scan rendering where 2D CT images, representing segments of a
person, are stacked in top of one another to create a 3D image of a patient’s injury. In
lower quality 3D CT images, it is possible to see the segments that are used to create it.
The singular rings represent segments of a cylindrical vessel. Each segment will be able
to withstand the mechanical properties of wall shear and hoop stresses; which capabilities
are in turn amplified when constructed into the complete vascular structure. A vascular
tissue construct made of segmental rings has additional benefits other than the ability to
build a larger cylindrical structure. The viable rings eventually will adhere together over a
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two-week period forming a continuous tube of tissue that is difficult to separate. This eliminates the chance of failure and leakage due to their ability to integrate. Individual rings
provide a simple means to control the structure of the engineered vessel created via this
method.
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CHAPTER 2 CUSTOMIZABLE 3-CELL LAYER VESSEL FORMATION
Attempts to construct blood vessels in vitro have been a goal of tissue engineering
for many years (Catto et al., 2014; Gui et al., 2014; Nemeno-Guanzon et al., 2012; Ravi
et al., 2010; Roh et al., 2010; Udan et al., 2013). Viable engineered vessels with functional
capabilities like native arteries have been shown to restore blood flow, and reestablish
hemodynamics (Quint et al., 2012). In Quint, et al. (2012), the engineered vessels are decellularized of their smooth muscle cells (SMCs) to increase biocompatibility, removing
the living, functional component, and in the end creating merely a scaffold. The SMCs are
very crucial as they allow the vessels to undergo vasoconstriction and vasodilation. Functions such as those must be preserved to create engineered vasculature with roles like
original vessels. In addition, there remains a significant need to vascularize engineered
tissues, mainly tissue patches and organs that have cell layers surpassing the diffusion
limit (Sekine et al., 2013). Without vascularization, the cells that make up engineered
tissues undergo necrosis, rendering the tissues useless. Two studies explored the creation of vascularization using perfusion, via the creation of elaborate bioreactors (Brewster
et al., 2007; Huang et al., 2011). Using a biodegradable tubular scaffold with a perfusable,
rotatable bioreactor, tissue resembling a vessel may be achieved (Quint et al., 2011). No
matter the method, these vascular substitutes are usually only built using one cell type,
not all three-cell types present in a normal blood vessel. Another proof of concept was
provided by a study that similarly joined singular rings to create a vessel (Gwyther et al.,
2011). There has been one other study that attempted to stack rings made of cancer cells
(Blakely et al., 2015). The rings created were on the order of micrometers in scale and
where stacked to form a capillary. Although their rings were much smaller in size and not
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quite designed for tissue applicability but as a proof of concept, their work represents the
feasibility of stacking rings of tissues.
Customizable vessels will open the range of disease states able to be studied, and
vessel types and sizes able to be treated. The framework for our work is based on the
use of 3D printed inserts to control size and shape of our vascular constructs, and is
rooted in our research group’s long standing expertise in cell sheet engineering (Lam et
al., 2009) and work derived from these discoveries (Raghavan et al., 2010).
3D printing techniques has been utilized as a means for building vascular structures. Miller et al. 3D printed a lattice of filaments of ‘‘liquid glass” composed of various
mixes of water-soluble sugars (Miller et al., 2012). The filaments were then encased in
poly (lactic-glycolic acid) (PLGA), the sugars dissolved, and endothelial cells seeded into
the PLGA channels. While the concept of an easily dissolvable sacrificial matrix is appealing, the end product is similar to seeding cells into hollow polymer fibers, a technique
long explored. Another popular technique has been to 3D build tissues by printing cells
encapsulated in CaCl2-based alginate hydrogels (Hoch et al., 2014; Zhao et al., 2015;
Datar et al., 2015), with the idea that entire organs could be printed cell by cell. However,
stacking cell droplets give rise to stabilization issues and creates the need to design intricate support structures. Torus shaped tissue was created via 3D printing SMCs mixed
with endothelial cells (Tan et al., 2014). In this study the researchers used a mixture of
SMCs and endothelial cells (ECs), preventing the final vascular construct from functioning
properly.
The foundation of our methods stem from the original work of Dennis and Kosnik
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(Dennis et al., 2000), where conditions were determined for self-organizing cell monolayers, or sheets, into cylinder-shaped tissues based on parameters of cell attachment, detachment and configuration of anchoring points, however constructs only formed 30–50%
of the time due to the weak extracellular matrix formed from the skeletal muscle cells
used. From there, Lam et al. enhanced those methods, including the addition of a thin
fibrin gel layer over the cells to keep the monolayer intact as it ‘‘rolled up,” drastically
improving successful construct formation to 80–100% of the time (Lam et al., 2009). In
conjunction with the Bitar group, these techniques were tailored for engineering of sphincter muscle through changing the cell type to colonic SMCs and adapting the anchor point
to a center post to form the cell sheet into a ring-like structure (Raghavan et al., 2010;
Hecker et al., 2005; Somara et al., 2009), though these methods are not easily modifiable.
The self-organizing cell sheet method is ideal for vascular tissue formation because it serves as a versatile platform for creating tissues of almost any shape and size,
based on configuration of anchoring points. To adapt these methods for readily customizable engineered blood vessels, a combination of a center silicone post and 3D printed
outer shells were created to modulate vessel lumen size and vessel wall thickness, respectively. These parameters are the main two factors that differentiate the varying blood
vessels, hence the ability to reconfigure these factors enables us to replicate nearly any
vessel in the body. As the cell sheet ‘‘rolls” inward toward the central post, the resulting
wall diameter of the tissue rings become dependent on the diameter of the monolayer
initially seeded. This variable is controlled by custom 3D printing an outer enclosure, the
diameter of which gives a close approximation of the desired wall thickness. By estab-
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lishing a fixed vessel wall size, a viable vessel can be consistently produced without concern of the diffusion limit for nutrient delivery being surpassed due to an overly thick wall.
Other aspects of construct formation were also redesigned to accommodate vascular engineering and to optimize ring formation. Most importantly, new methods were developed
to create a tubular structure, by intricately creating and securing ring stacks. Our resulting
rings display increased expression of smooth muscle genes actinin IV and Calmodulin
compared to SMCs in culture. Actinin IV is an actin cross-linking protein which directly
affects the number of contractile components (Sun et al., 2015). In smooth muscle, Calmodulin serves to activate the cross-bridge cycle, leading to force development (Walsh
et al., 1994). The rings and ring stack construct also exhibit good mechanical properties
as determined by tensile testing. Histology revealed an organized SMC layer indicative
of vascular tissue. These methods introduce a previously unattainable way to create customizable engineered vascular tissue useful for numerous applications.
Materials and Methods
Cell culture
The cells utilized were human aortic smooth muscle cells (SMCs), human dermal
fibroblasts, and human umbilical vein endothelial cells (HUVECs) that were purchased
from American Type Culture Collection (ATCC) (PCS 100-012, ATCC, VA). The SMCs
are maintained in a SMC growth media composed of 88.6% 231 media (SH30243.01,
Hyclone Laboratories, UT); 0.1% each of recombinant human insulin (rH-insulin), recombinant human fibroblast growth factor (rH-FGF), recombinant human epidermal growth
factor (rH-EGF), and ascorbic acid; and 5% each of fetal bovine serum (FBS) and Lglutamine; and 1% antibiotic/antimycotic (15240-062I, Gibco, MA). All growth factors,
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FBS and L-glutamine were purchased as a vascular smooth muscle cell growth kit (PCS
100-042, ATCC). Fibroblasts were maintained in fibroblasts growth media composed of
89% Dulbecco’s Modified Eagle Medium (DMEM) (company info), 10% FBS and 1% antibiotic/antimycotic. HUVECs will be cultured in EC growth media composed of 91.3% 131
media, 2% FBS, 5% L-glutamine, 0.1% ascorbic acid, 0.1% recombinant human insulinlike growth factor (rH-IGF), 0.1% rH-FGF, 0.1% rH-EGF, 0.1% heparin sulfate, 0.1% recombinant human vascular endothelial growth factor (rH-VEGF), and 0.1% hydrocortisone. The media was changed every 48 h until the cells are ready to be placed in a
hydrogel as described below. In between media changes, the cells are stored in an incubator (Heracell 150i, 50116056PR, ThermoFisher, NC) for expansion.
Preparation of 3D printed inserts
The ‘‘Micro” manufactured by M3D (M3D LLC, MD) was used for 3D printing the
plate inserts. The 3D models of the printed shells were created using Blender, an open
source 3D design software (Blender Foundation, Amsterdam, Netherlands). The model’s
driver file was exported in an .stl format in order to open it in the 3D printer’s software
(M3D Beta Version 1 3.6.3). Instructions provided in the manufacturer user’s guide were
followed. The printed shell was produced using clear poly (lactic acid) filament (PLA, 3D
Ink Crystal Clear) loaded into the 3D printer. Following printing, a 30-min soak in a 40%
bleach solution was used to sterilize each shell. Then printed shells were removed from
the bleach and submerged in 70% – 200 proof ethanol for 30 min. The printed shells were
then ready for custom plate creation.
Assembly of custom silicone molded plates
A 1:10 curing agent to base polymer mixture of poly(dimethylsiloxane) (PDMS)
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silicone polymer (Sylgard 184, 1064291, Dow Corning Co, MI) was prepared. Four milliliters of the uncured silicone were added to each 35-mm petri dish to create a thin layer
across the entire bottom of the plate. Prior to complete curing of the PDMS, a 3D printed
outer shell was centrally placed into each dish. The dishes need to cure for 48 h in open
air to fully degas the polymer. After curing, the printed shell remained fixed to the plate in
the proper location and orientation. To create center posts, PDMS was poured into a 100mm plate to a height of 7 mm and allowed to cure uncovered in room air for 48 h. After
this period, a 5-mm diameter biopsy punch (33 35, Miltex, PA) was used to punch out
cylindrical posts for tunica media ring formation. A similar 6 mm diameter biopsy punch
was also used to create a post for tunica adventitia ring formation. A small amount of
uncured PDMS was applied to the bottom of each PDMS cylinder and then it was placed
at the center of the 3D printed outer shell previously adhered to the 35-mm petri dish.
One day prior to cell seeding, a paintbrush was used to apply a thin layer of PDMS to the
inside of the printed outer shells. This required step prevents adherence of the hydrogel
described below to the printed shell allowing the cell monolayer to roll up freely. The plates
were air dried overnight, uncovered. Once the PDMS has completely cured, the plates
are moved into a biological safety cabinet (BSC). A solution of 70% ethanol (2705, Decon
Laboratories, PA) with 30% distilled water (W5-4, Fisher Scientific, NJ) was added for 30
min to the inside of each printed shell for the purposes of sterilization and then each plate
was covered. The ethanol was carefully aspirated from each plate and the plate allowed
to completely air dry. The plates are arranged under the hood with each plate set next to
its lid, face-up. The plates are exposed to UV light under the BSC for an additional 30
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min. Every step after UV exposure was performed with sterile technique to avoid contamination.
Fibrin Gel
When an abrasion is caused where skin is lost and bleeding occurs, the body has
a built-in safety mechanism to temporarily stop the bleeding and seal the wound this is
called the blood coagulation (clotting) mechanism. As soon as a blood vessel is damaged,
normally inactive coagulation factors circulating in the bloodstream are activated. Components in the blood such as platelets stick to the area along the with red blood cells and
this forms a clot. This is accompanied by fibrin strands which forms when thrombin converts fibrinogen into fibrin. On the molecular level fibrinogen’s b dimer which is composed
a and b chain is cleaved by thrombin creating fibrin. This allows the E domain to have the
potential to bind to a neighboring fibrin’s D domain forming a bond. While undergoing
curing neighboring D domains in the biopolymer will bind to form a D dimer. This providing
fibrin gel with a fibrous microstructure although it appears as a gel to the naked eye.
Fibrin gel makes for an ideal biomaterial to use when creating engineered tissues
due its biocompatibility with cells and the degradation rate. Generally, fibrin gel degrades
in about 2 weeks. Also, the hydrogel may be curried with necessary growth factors and
nutrients. This allows the cells to proliferate and express the genes necessary to put down
extracellular matrix, while creating cell to cell junctions. Also, like curing of polymers stiffness of fibrin gel can be modified by increasing the volume of thrombin (solvent) utilized.
Details on how it is used for the construction of RMSTEVs we will described in further
detail.
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Preparation of fibrin hydrogel
As described in our previous work (Lam et al., 2009), the addition of a thin fibrin
gel to the cell monolayer aids in keeping the cell sheet intact during the roll up process,
drastically improving the success rate of construct formation. Thus, a fibrin gel was created in a solution of media to enrich the cells. Growth media, in the amount of 250 microliters, was added to the inside of each printed shell in each plate. Twenty microliters of
thrombin, from a stock of 100 U/ml, (7592, Biovision, CA) was added to the media in each
plate. The plate was then manually agitated to ensure that the media thrombin mixture
covered the entire bottom of the plate inside the printed shell. While this step is timeconsuming due to the hydrophobic nature of the PDMS substrate, an even coating of
media will ensure proper formation of the hydrogel. Once distributed, 80 microliters of
fibrinogen were added drop-wise circularly to the thrombin-media mixture in each plate.
The plate was briefly swirled clockwise, distributing the hydrogel into an even layer. By
keeping this swirling time brief, the fibrin hydrogel sets evenly without ripples or holes.
The plate is then set aside for fifteen minutes to ensure complete curing of the hydrogel.
Seeding of hydrogel with smooth muscle cells
Smooth muscle cells in expansion plates were trypsinized and centrifuged. The
resulting pellet was re-suspended in differentiation media composed of 98% 231 media,
1% FBS and1% antibiotic/antimycotic. One ml of differentiation media was used for resuspension per each cultured 100 mm petri dish of smooth muscle cells. The cell suspension was vigorously mixed with a 1000 ml pipette to break up any cell clumps. Cells
were then counted with a hemocytometer (3200, Hausser Scientific Co., PA). A 2 ml of
the cell suspension, containing about 1x106 cells, was carefully pipetted on top of the
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prepared fibrin hydrogel inside the printed shell drop-wise. Although the fibrin gel is mostly
cured at this point, due to its softness, it is still possible to disturb its surface by adding
the prepared media too vigorously. The plates were covered and placed in the incubator
at 37˚C and 5% CO2. Maintenance of seeded hydrogel plates Each plate was examined
by light microscopy daily. This allows for evaluation of cellularity, possible contamination
and observation of cellular self-organization. By 24 h after cell seeding, integration of the
smooth muscle cells into the fibrin hydrogel can be seen, and the edges of the hydrogel
will have begun to detach from the printed shell, allowing the cell sheet to begin to roll
toward the central cylindrical post. Forty-eight hours after seeding, the differentiation media in each plate was carefully aspirated. This step must be performed with care; at this
early stage the hydrogel may still be adherent to the interior of the printed shell and excessive agitation will disrupt the formed gel. Any disruption at this phase will hamper the
organization of the smooth muscle cells in the hydrogel. This can result in irregularly organized or asymmetric rings, or in tears and holes within the gel itself. Two ml of fresh
differentiation media is then added to each plate. This procedure is repeated every 48 h
to ensure cell viability within the hydrogel. At approximately 72 h, cell sheets will begin
self-organization into ring structures. The fibrin hydrogel, embedded with smooth muscle
cells, will contract toward the central PDMS post in each plate. Occasionally, much of the
circumference will have completely rolled centrally with the remainder being held to the
printed shell by a small ‘tether’ of hydrogel. This can be carefully agitated with a Pasteur
pipet or another fine sterile pipette tip. This rolling process will continue for up to seven
days past cellular seeding. A seeded hydrogel is considered a successfully completed
ring when it has rolled tightly around the central PDMS post symmetrically without tears
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or detachment. At this point, a tightly rolled, dense hydrogel can be observed.
Seeding of hydrogel with fibroblasts
Fibroblast expansion plates were trypsinized and centrifuged. The resulting pellet
was re-suspended in fibroblast growth media containing the exact same components descried earlier. Three ml of growth media was used for resuspension per each conical of
centrifuged cells used. The cell suspension was vigorously mixed with a 5-ml pipette to
break up any large clusters of cells. Cells were then counted with a hemocytometer. A 2ml cell suspension, containing about 2.5x105 cells, was carefully pipetted on top of the
prepared fibrin gel inside of the printed shell drop-wise. Next add, 150 microliters of 1
mg/ml ascorbic acid to the media. Following this addition, pipette 10 µl of 10 ng/µl TGFb1. Plate were then covered and placed in the incubator. Growth media must be changed
after 48 h along with new additions of both ascorbic acid and TGF-b1. After about 72 h
rings begin to form. On day 4 change the media to the same differentiation media used
for the smooth muscle cells, without any addition of the two growth factors. By day 7
fibroblast ring formation is complete with a tightly rolled dense engineered tissue wrapped
around the 6-mm post.
Tunica media construct assembly
Prior to construct assembly, a specialized plate is created to hold the completed
ring stack, or vessel. A PDMS substrate was prepared by adding 10 ml to a 100-mm dish
and cured for 48 h. Utilizing a 5-mm biopsy punch, two cylindrical posts were punched
from this dish. Using a small amount of freshly prepared, uncured PDMS, 2 cylindrical
posts were glued vertically atop one another, then attached to a separate 100 mm dish.
The taller PDMS post needs to cure for 24 h. The plate with the tall PDMS center post
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was sterilized with a 30-min soak of 70% ethanol, followed by 30 min of UV sterilization
in a BSC. Using very fine forceps (11251-30, Fine Science Tools, Inc., CA), each tightly
rolled smooth muscle hydrogel ring was carefully withdrawn from its PDMS post and
transferred to the tall PDMS post. This is best accomplished with a pair of forceps in each
hand, lifting one side of the ring from the PDMS post then the other, being careful to
protect and maintain the lumen. The transfer was performed with this two-handed
method, sliding first one side, then the other side of the ring onto the tall PDMS post.
Using gentle, gradual movements, and working circumferentially, the ring is slowly
pushed down onto the tall post. Several rings are subsequently stacked until the desired
vessel length has been obtained, with each ring adding approximately 1–2 mm of length
to the completed construct. With the ring stack positioned on the tall PDMS post, the plate
is turned so that the PDMS post is parallel with the working surface. Using a fine pipette,
40 ml of thrombin at a concentration of 100 U/ml was gently applied. While adding this
thrombin, the plate was slowly rotated to ensure even coverage of all surfaces of the
construct. This will be the base for the fibrin glue utilized to improve the ring stack construct integrity in the initial days after construction. Once applied, 40 µl of fibrinogen at a
concentration of 20 mg/ml was added to the construct using a fine pipette, rotating the
construct quickly. The thrombin and fibrinogen quickly set into a firm gel once mixed. Due
to the short curing time, the fibrinogen should be applied as quickly and evenly as possible.
Bilayer Ring Assembly
After the formation of both smooth muscle cell and fibroblast rings bilayer ring assembly was commenced. Take both plates containing smooth muscle cell and fibroblast
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rings. Then aspirate the media in both plates containing the rings. With a pair of the same
fine tipped forceps used earlier remove the fibroblast ring from the 6-mm post. Following
this wrap the fibroblast ring around the smooth muscle cell ring within the same plate.
After the fibroblast ring was securely around the smooth muscle ring adding fibrin glue to
adhere the two layers. Initially pipette 100 µl of thrombin in between the rings, followed
by 100 µl of fibrinogen. Place lid back on the plate and let cure at 25°C for about 5-10
minutes. Pipette 2 ml of differentiation media to the cured bilayer ring and place in the
incubator. Let sit in the incubator for about 48 h before use.
Bilayer Vessel Assembly
Bilayer vessel construction was created in a similar manner as the tunica media
vessel with use of fibrin. Using a micro pipette, add 100 µl of thrombin at a concentration
of 100 U/ml was gently applied. Followed by an application 100 µl of fibrinogen at a concentration of 20 mg/ml using a micro pipette, while rotating the construct quickly. Allow
the fibrin glue to cure for 5-10 minutes. After which add 12 ml of differentiation media
place the tall plate with the bilayer vessel in the incubator for at least 4 days.
Bioreactor Preparation
Place bioreactor in an open glass container then slowly fill it entirely with 70%
ethanol. Then place a heated plate set to 90°C in a cell culture biohood. Place the bioreactor with the ethanol filled glass plate on the heated plate, then UV sterilize for 1 hr.
Following this remove the bioreactor from the plate filled with ethanol. Discard the plate
filled with ethanol. Place a 12rpm peristaltic pump, magnetic stir plate, along with the
bioreactor heating control system inside of the biohood after first spraying then down with
70% ethanol. Then UV for 1 hr. Following UV sterilization cover the bioreactor with the lid
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then place a beaker with autoclaved silicone tubing inside the biohood. Connect tubing to
the bioreactor.
Static Tunica Intima Seeding
Autoclave PDMS seeding outer shell (PSOS). Sterilize Static HUVEC seeding
plate, PLA tube fittings, magnetic stir bar and PDMS stopers with 70% ethanol for 30
minutes then UV sterilize the plate for 30 minutes. Place the PLA tube fittings on each
end of the PSOS, then seal with the PDMS stoppers on each end of the PLA fittings.
Place the PSOS + PLA fittings on the holders in the static HUVEC seeding plate. Cover
the plate with the lid. Take the vessel out of its tall plate and gently place in the PSOS
with sterile fine tipped forceps. Do this by opening removing the PLA tube fitting at one
end of the PSOS. Be sure the ensure the lumen of the vessel stays open. Take 1 x 150
mm plate of HUVECs then wash and aspirate twice with 4 ml of PBS, followed by an
incubation at 37°C with 2 ml of trypsin for 5 minutes. Lightly tap the plate to dislodge cells
then wash down with 3 ml of EC GM. Centrifuge at 2000 rpm for 5 minutes at room temperature. Then resuspend the cells in 600 µl of EC GM. While the PLA tube fitting is
removed, slowly pipette the 600 µl of HUVECs with a 1000 µl pipette. Then place the tube
fitting back on the PSOS. Place the PSOS + tube fitting + vessel on the holders of the
static EC seeding plate. Cover with the lid and gently place into incubator for about 1-1.5
hours then aspirate cells and media gently. Repeat steps 5-9 two more times rotating
120° each time.
Dynamic Tunica Intima Seeding
Autoclave silicone tubes and polycarbonate (PC) valves, glass media reservoir,
media reservoir lid and stainless-steel screws. Take 15 x 150 mm plate of HUVECs then
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wash and aspirate twice with 4 ml of PBS, followed by an incubation at 37°C with 2 ml of
trypsin for 5 minutes for each plate. Lightly tap the plate to dislodge cells then wash down
with 3 ml of EC GM. Centrifuge at 2000 rpm for 5 minutes at room temperature. While
cells are in the centrifuge add the magnetic stir bar and 120 ml of EC GM + 3ml of HEPES
solutions to the media reservoir. After cells centrifuge resuspend them in the 3 ml of EC
GM taken from the media reservoir. Add the resuspended cells into the media reservoir.
Take the PSOS + tube fitting + vessel out the incubator and carefully aspirate the cells
and media. Transfer the PSOS + tube fitting + vessel and media reservoir to the bioreactor. Connect PSOS + tube fitting + BEBV to the bioreactor using sterile silicone tubes.
Connect flow silicone tubes to the media reservoir. Screw the lid onto the bioreactor using
the stainless-steel screws. Place the Arduino and heating pads into the incubator after
spraying them down with ethanol. Place the media reservoir on the 150 mm plate + PDMS
+ heating pad. Then place the bioreactor on top of the bottom plate heating pad, use the
stainless-steel screws to tightly connect the bioreactor to the heating pad. Place the thermometer in the thermometer hole of the bioreactor. Add tape to the thermometer and the
front of the bioreactor heating plate where the wires are sticking out off. This seals the
bioreactor to keep the heat in. Plug in all connections in this order: pump, heating pads 1
and 2. Following this check the Arduino Thermal Controller (check screen for these values): T1 (Bioreactor Temp) and T2 (Media Reservoir). Run Bioreactor for about 24 hours.
Then remove vessel for further analysis.
Polymerase chain reaction
The rings were dissociated with a micro tissue homogenizer (Kimble ChaseTM
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BioMasherIITM Closed System Micro Tissue Homogenizer, K7496250010, ThermoFisher) and then centrifuged at 1000 rpm for 5 min to form a pellet. Controls consisted
of SMCs cultured for 3 days to retain consistency with the amount of time the rings were
in culture. RNA purification was carried out with an RNA purification kit (GeneJET RNA
Purification Kit, FERK0731, ThermoFisher). The concentration of RNA of the sample in
ng/ml was measured with a Qubit 2.0 Fluorometer (Q32866, Invitrogen, Foster City, CA).
Complementary DNA preparation was completed with the Taqman Reverse Transcription
Reagents kit (N8080234, Applied Biosystems, NJ). Each prepared PCR sample was
placed in a thermal cycler (2720, Applied Biosystems, MA) and run for 10 min at 25 °C,
then 30 min at 48 °C, and finally held at 4 °C until PCR was run. qRT-PCR was conducted
using a StepOne Plus Real-Time PCR system (4376600, ThermoFisher) with the accompanying StepOne PCR software (v 2.2.2, Applied Biosystems, CA).
Tensile testing.
Tensile testing was conducted on an Instron 5943 with BlueHill 3 software (Instron,
Norwood, MA). Tensile testing was performed at a rate of 0.4 mm/min. Samples were
installed in the Instron using custom steel hooks. Sand paper was glued to a piece of
foam to create grip pads which were then attached to the steel hooks, coated with plastic
to decrease the chance of vascular tissue tear. The samples were then looped around
the hooks prior to stretching. These grips were used for both individual ring and vascular
construct tensile testing. Upon installation, the initial length of each sample was measured
using calipers to determine original ring or construct length to calculate strain. Groups
stretched to failure were: individual rings (n = 6), constructs strained circumferentially (to

23
test radial strength needed for active blood flow, n = 4), and constructs strained longitudinally (to test strength between rings, n = 1). Full constructs were cultured for 3 days
prior to tensile testing.
Histology
Engineered rings were fresh fixed into optimal cutting temperature (OCT) compound, cryosectioned into 10 lm cross-sectional and longitudinal sections, mounted onto
slides, and air-dried overnight prior to staining. Samples were stained with hematoxylin
and eosin (H&E) and Masson’s Trichrome stain. In H&E stained samples, the purplish
structures shown indicate cell nuclei, while pink regions indicate cytoplasm and residual
fibrin gel. In the Trichrome sample shown, muscle cells stained red and nuclei black. For
immunohistochemistry, samples were stained with antibodies to tropomyosin (labeled
with FITC) or caldesmon (labeled with Alexa Fluor 647), both of which are proteins involved in smooth muscle contraction. DAPI was used as a counter-stain. Endothelial cells
were stained via Ulex Europeaus Agglutinin (UEA-1) stain to validate seeding via static
and dynamic processes.
Statistics
All averages are reported as mean values ± standard deviation. ANOVA with
Tukey post hoc test was performed for PCR results. Student’s T test was run on tensile
data. Alpha value was set to 0.05. Statistical analysis was performed in Microsoft Excel
software. No significant different results were found.

Calculations
In the initial phases of formulating this protocol, a smooth muscle cell ring model
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was established using the methods outlined above inside of a 35-mm petri dish with a 5mm central PDMS post. The wall thickness of the resulting vessel rings, averaging to
1000 lm, was measured and correlated to the diameter of the plate used. This correlation
was translated to the following equation:
!!
"!

!
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Equation 2-1.

"

where r0 and t0 are the radius from the central post and the thickness of the resulting
vessel wall in the standard 35 mm petri dish and rx and tx represent the desired vessel
wall thickness and plate radius required to achieve it, respectively. Utilizing the value obtained for the necessary plate radius, rx, we could use the 3D printing techniques and
technology to produce a printed outer shell with any desired value of DOS:
𝐷#$ = 2𝑟% + 𝐷&

Equation 2-1.

where 2rx is the inner diameter of the printed shell and Dp is the diameter of the PDMS
post. This allows for customization of the thickness of the vessel wall to mimic a variety
of native vessel sizes. A diagram describing each variable in the equations is shown in
the Supplementary Material.
Results
Successful ring stack method
A schematic of the overall process of the ring formation process is shown in Fig.
2-1A. Images of the ring formation in culture are shown in Fig. 2-1B–D. In Fig. 2-1B and
C, ring stacks with 6 rings per construct are shown on the tall PDMS post. In Fig. 2-1D,
the progression of self-organization of a single ring is shown. The edge of the gel with
cells on top of it can be seen rolling in from the edges of the 3D printed shell toward the
center PDMS post, eventually aggregating at the center post into a ring structure. It takes
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Figure 2-1. Formation of Engineered Tunica Media Vessel. Schematic of plate creation including seeding (A).
Overhead (B), and front (C) view of TEV created via the RSM. 3-day ring formation process where ring fully contracts in 3 days (Pinnock et al., 2015).

approximately 3–5 days for a ring to form.
Key smooth muscle genes slightly increased
To ensure that our vascular construct can mimic the tunica media of an anatomic
vessel, we compared the expression levels of several genes known to be expressed by
smooth muscle cells to our rings (Fig. 2-2). SMCs were cultured for 3 days were used as
controls for genetic expression. The individual ring segments exhibited a slight (non-significant) increase in Calmodulin and a-actinin-IV expression compared to the cultured
smooth muscle cells. Collagen I, in comparison, was approximately the same for the individual rings. Collagen X expression, a cell hypertrophic marker, was very similar for
both the culture SMCs and the individual rings, indicating that the cells in the ring remained viable. Ring stacks exhibit additive mechanical properties.
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Tensile results
are shown in Fig. 2-3.
The tensile setup with
a ring stack construct
is shown loaded into
the Instron for testing
(Fig. 2-3A). Individual smooth muscle

Figure 2-2. RNA-PCR Analysis observing collagen I, alpha-actinin IV, calmodulin, and collagen X. 2D cultured hSMCs in blue (control) and 3D tissue engineered
rings in orange (Pinnock et al., 2015).

cell rings (n = 6) and ring stack constructs (circumferentially: n = 4; longitudinally: n = 1)
were stretched until failure. For the rings, the mean elastic modulus was 15.2 ± 2.35 kPa,
with the mean ultimate tensile strength at 16.6 ± 2.45 kPa, and mean failure strength at
16.3 ± 2.57 kPa (Fig. 4B). Circumferential tensile testing of the full vessel was performed

Figure 2-3. Tensile Data. Six ring engineered vessel (center yellow arrow) being stretched to failure with customized grips (top and bottom yellow arrows) via Instron (A). Circumferential stress-strain relationship of individual rings (B). Circumferential stress-strain relationship of sex ring engineered construct (C). Longitudinal stressstrain relationship of sex ring engineered construct (D). Table comparing Elastic Modulus, Ultimate Tensile
Strength, and Failure Strength of all three graphs (E) (Pinnock et al., 2015).
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with an engineered vessel composed of 6 ring segments in order to test the radial strength
of our engineered constructs. Construct radial strength is critical for withstanding physiological hemodynamics. During the tensile testing of the full engineered vessel, the weakest segments failed first followed by the stronger segments. After tensile testing the construc ts circumferentially (n = 4), the elastic modulus was found to be 126 ± 4.45 kPa, the
ultimate tensile strength at 191 ± 3.40 kPa, and the failure strength at 177 ± 2.49 kPa
(Fig. 2-3C). The constructs were tested longitudinally after 3 days in culture to determine
strength of the attachment from ring to ring. Longitudinally, the constructs’ elastic modulus
was 14.2 kPa, the ultimate tensile strength was 17.9 kPa, and the failure strength was
11.9 kPa. Exact numbers are shown in the chart in Fig. 2-3D. There are no standard
deviations for the longitudinally tested construct because the number of samples was 1.
Smooth muscle cells in rings exhibit organization
The staining of the smooth muscle hydrogel rings was completed with both hematoxylin and eosin (H&E) staining, as well as a trichrome stain. Fig. 2-4A and B demon-

Figure 2-4. H & E and Trichrome Stain. In situ H & E (A), and Trichrome (B) stain. Cross sectional view of ring
via H & E stain (C & D). In situ H& E full view of ring (E) (Pinnock et al., 2015).

strate the appearance of hydrogel-embedded smooth muscle cells at the cusp of a ring
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rolling toward a central PDMS post, located at the bottom-right of the images. Note that
the unrolled portions of the ring, closer to the central post, show a markedly less dense
cellularity while the cells further away from the post are not only more, dense, but show
a circumferential organization. This reflects the rolling action of the cell-embedded hydrogel and the self-organization of the cohort of smooth muscle cells. The H&E and Trichrome stains show both the presence of cell nuclei in the well-organized manner and
healthy cellularity. The cells display a clear longitudinal orientation, a reflection of the
robust self-organizing properties of the smooth-muscle cell embedded hydrogel. Connections between the SMCs are also observed, indicative of cell–cell junctions. The lack of
blue-green staining in the Trichrome stained image, indicating the lack of collagen, correlates with the PCR results. In Fig. 2-4C and D, the cross-sectional view shows dense
cell content, with purplish areas demarcating cell nuclei and pink areas indicating residual
fibrin gel. Fibrin gel generally degrades within 2 weeks in vitro, and very little remains in

Figure 2-5. IHC Stain. Nuclei stained via DAPI in blue (A & D), Tropomyosin in green (B), Caldesmon red (E), and
merged images (C & F) (Pinnock et al., 2015).
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these 3 day pictures. It was noted that the amount of fibrin gel present at specific time
points varied between tissue rings. Fig. 2-4E shows H&E staining of a ring, with pink and
purple colors indicating cellular content. The edges that appear frayed are an artifact of
histology sectioning. Overall, the rings are circular and have a stable inner lumen.
Smooth muscle rings demonstrate contractility
After 4 days in culture, i.e. from the point of complete tissue ring formation, spontaneous contraction was observed in several SMC rings under a light microscope. The
rings were not actively stimulated to induce contraction, meaning no electrical or chemical
stimulation was added during culture. The cause of spontaneous contraction of muscle
cells in culture is not well understood, though this action clearly demonstrates functional
capacity of our engineered rings. Individual cell contraction could not be seen. Rather,
the cells contracted in synchrony, moving the entire field of view under the microscope
during each contraction, which is also a result of the cells being on the fibrin gel. Additionally, the engineered rings stained positively for antibodies to tropomyosin and
caldesmon, contraction-associated proteins (Fig. 2-5). Fig. 2-5A–C show stains for tropomyosin tagged with FITC. Residual fibrin gel can be seen in these images (lattice-like
structures). Fibrin gel degrades by 2 weeks in culture, hence the amount of fibrin gel seen
in some of the rings is temporary. Fig. 2-5D–F shows positive stains for caldesmon.
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Bilayer Ring and Vessel Construct
Bilayer ring formation proved successful as both SMC and fibroblast layers were
adhered via the fibrin glue (Fig. 2-6A). The two ring layers were clearly defined. Rings
were easy to maneuver with fine tipped forceps. Attempts to pull away the two layers were
difficult. The vessel also resembled similar features as the two layers were easily distinguishable (Fig. 2-6B). Again, it was difficult to separate the two layers from each other.
Intima Seeding
The PSOS was used successfully, vessels were easily placed inside and were
able to be visualized as well as no leaks were observed while static seeding (Fig 2-7A).
Arduino Thermal Controlled Bioreactor proved to operate successfully both T1 and T2
temperature values of 37.1 degrees Celsius was maintained (Fig 2-7B and C). The
12rpm motorized pump held a consistent flow rate of 20 ml/min. HUVECs were visualized

A

B

Figure 2-6. Bilayer ring held and stretched via two forceps (A). Frontal view of bilayer vessel construct. Both exhibited distinct layers that were firmly adhered to one another.
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Figure 2-7. Static HUVEC seeding plate with the PDMS seeding outer shell (PSOS) + tube fittings + vessel (A).
Entire bioreactor setup for dynamic intima seeding (B) where the PSOS was perfused with HUVECs at a flow
rate of 20 ml/min (C). Immunofluorescence stain of the vessel after static and dynamic HUVEC seeding combination: nuclei stained via DAPI in blue (D), HUVECs stained via Ulex Europeaus Agglutinin in orange (UEA-1)
(E), proceeded by a merged image (F). (Scale bar = 400 µm)

via a UEA stain showing that the combined static and dynamic seeding was successful
(Fig 2-7D-F). The HUVECs were visible along the lumen of the vessel and appear to be
making connections similar to that of the intima layer seen in native tissues.
Discussion
In vivo, vasculature is subject to constant and pulsatile radial stress. The SMCs in
the media layer of the vessel are adapted for this pressure and contract in response to
distention to reduce overall strain on the vessel wall. Hence, tensile testing was arranged
to induce radial strain on the singular rings and the full construct to mimic forces experienced by vessels in vivo. The tunica media layer in vessels provides contractile forces
that can allow distention under high pressure. Therefore, an engineered vessel must possess similar elasticity. Previous researchers have determined the mean uniaxial ultimate
tensile strength (UTS) for the tunica media layer of a common iliac artery to be 188.8 ±
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110.9 MPa (Sommer et al., 2008). Our engineered vessel exhibited a circumferential ultimate tensile strength of 191 ± 3.40 kPa, displaying a 3-fold difference in strength. This
difference is likely due to the lower amount of natural extracellular matrix evident with our
construct, which is due to the differences between in vivo and cell culture conditions.
Despite this difference, our engineered rings and vessel showed considerable integrity.
This integrity is also shown in the fact that the rings and construct can be easily handled
with forceps.
The engineered vessel has a circumferential ultimate tensile strength much greater
than the ultimate tensile strength of the individual rings (191 kPa vs. 16.6 kPa, respectively), showing the augmentative strength of our ring stacking method. Interestingly, the
difference in UTS is about 11.5_ higher, which correlates roughly with double the number
of rings in the construct (6 rings), meaning that there is an additive effect of the rings in
series. There is a lack of data concerning the individual failure strength and elastic moduli
of native vessels, as the process of tissue dissection and the extraction of the vessel from
its natural milieu has significant impact on its integrity. A study of the failure strength of a
series of isolated coronary artery media layers reveals that the failure strength of our
construct is within reach of the in vivo figure of 390 ± 70 kPa (Elices et al., 2010). The
lower failure strength of our construct (84.3 kPa) is likely explained by the reduction in
collagen produced by cells, as seen in the PCR data. This collagen, among other similar
connective tissue, provides a great amount of a vessel’s failure strength.
Longitudinal tensile testing of the full construct revealed that the strength between
the rings while in the construct was nearly equivalent to the strength of the fibrin gel holding the construct together. For elastic modulus, our construct’s value of 14.2 kPa lies

33
within the range of fibrin gel which is 9.2–34.5 kPa (Sierra et al., 2002). Similarly, for
ultimate tensile strength, fibrin gel is reported to be in the range of 7.4–31.3 kPa (Sierra
et al., 2002), with our construct’s value at 17.9 kPa. Constructs were cultured for 3 days
prior to tensile testing to allow time for the SMCs to migrate and expand across the ring
junctions. From this data, it appears that a longer time in culture may be needed for integration of the rings into a more cohesive construct.
The relative increase in a-actinin-IV and Calmodulin is likely due to inward contraction of the smooth muscle cells on the fibrin gel as the cell-hydrogel complex tightens
against the PDMS post. In standard tissue culture, smooth muscle cells contract in response to biologic feedback, as in a blood vessel, but due to standard cell culture parameters the majority of cell types cultured in a petri dish remain static. The hydrophilic fibrin
gel provides the cells with a more pliable surface, contracting centrally against the hydrophobic PDMS surface below. For smooth muscle contraction to occur, Ca2+ ions must
bind to Calmodulin, initiating a cascade which eventually activates cytoskeletal proteins
including a-actinin-IV, resulting in smooth muscle contraction. Since the smooth muscle
cells in the individual rings are contracting actively in their movement toward the central
PDMS post, as reflected at the gel edges in Fig. 4A, Calmodulin expression is likely increased in return as seen in our PCR data. In vivo, collagen serves as an extracellular
environmental support for smooth muscle cells and, along with other support proteins,
helps form an established tunica media. In contrast, the smooth muscle cells in our experimental protocol are contracting fluidly, a rearrangement which diminishes the immediate need for collagen deposition. Maintaining these cells in culture, or in a native vessel,
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demonstrates an increase in collagen synthesis, and thus in overall tensile strength. Collagen X expression, a cell hypertrophic marker, was similar for both the culture smooth
muscle cells and the individual rings, showing that the cells in the ring remained healthy
by not undergoing hypertrophy.
Smooth muscle contraction is mediated by the interaction of myosin and thin filaments, which together form the actomyosin complex. The thin filaments consist of actin,
tropomyosin, caldesmon, and calmodulin. Actomyosin activation is amplified by smooth
muscle tropomyosin (Marston et al., 2008). Caldesmon and calmodulin control the tropomyosin-mediated shift from on and off modes for contraction. Positive immuno-staining in
our tissue rings for tropomyosin and caldesmon indicate presence of contractile proteins
in the SMC contraction machinery. Caldesmon is associated with actin and tropomyosin
in smooth muscle thin filaments, and is distinctly found in the actomyosin domain, further
showing caldesmon’s association with the contractile apparatus (Pritchard et al., 1986).
Additionally, the synchronized, spontaneous contractile movement may suggest that adherens junctions had formed between the smooth muscle cells, allowing for force transduction across several cells through the connecting dense bodies which are attached to
the adherens junctions.
Our human aortic smooth muscle cell construct serves as the media layer. The
additional layers, the intima and adventitia, confer vital functions to a blood vessel. The
intima, composed of endothelial cells, provides the optimal conditions for proper hemodynamics, produces heparin sulfate as an anti-thrombogenic agent, and serves as the
location of platelet adhesion and fibrin clot formation during injury. The adventitia, composed of collagen producing fibroblasts, provides strength and protection for the vessel.
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To ensure optimal function, an engineered vessel should have an intima, media and adventitia. The unique aspect of our novel ring stacking method is that it can also be applied
to other cell types. Though contractile cells work best to aid in the rolling-up process, we
are able to form tissue rings of non-contractile cells such as fibroblasts, as seen in the
creation of the bilayer rings and vessel construct. Via combined methods of statically and
dynamically seeding, we are able to create an intima layer inside of our vessel construct.
Using this same technique to control the wall thickness of the vessel we are it is
possible to scale up the individual rings. This is so physiological wall thicknesses may be
achieved after rings have formed. Allowing for potential disease modeling of the various
different blood vessel found in the human body.
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CHAPTER 3 SCALING OF TISSUE ENGINEERED VESSELS
Scalability is of utmost importance for engineering vessels to meet the wide range
of vessel sizes found throughout the human body. Creating large scale in general poses
the ability to design atherosclerosis models to understand pathology at various sizes.
However, present methods for engineering vessels are not easily scalable, and typically
require remanufacture of complex molds or polymer scaffolds. Most engineered grafts
either utilize a polymer tubular scaffold that is seeded with vascular fibroblasts, smooth
muscle, or endothelial cells; or rolling a cell sheet around a mandrel to create a tissue
tube. Two engineered vascular grafts in clinical trials are based on a de-cellularized polymer-ECM platform (Lawson et al., 2016; McAllister et al., 2009; Wystrychowski et al.,
2014). Polymer grafts available for use in vascular repair are already known to have issues with patency, which could arise as a major issue with long-term application of a graft
with a sustained polymer presence. Tubular molds have been used to fabricate completely cellular vessels, (Dahl et al., 2011; Gui et al., 2014; Konig et al., 2009; Meir et al.,
2014; Quint et al., 2011; Quint et al., 2012; Sundaram et al., 2014; Syedain et al., 2011;
Syedain et al., 2014) which procedures would require additional design and tool manufacturing for custom molds to produce vessels in a variety of sizes.
The method described herein encompasses a novel technique for creating easily
scalable engineered vascular grafts using customizable 3D printed inserts and traditional
culture plates. Cells are seeded into plates with inserts composed of a central post and
outer shell-like chapter 2. The post controls lumen diameter and allows the cell monolayer
to self-assemble into a ring of tissue. The outer shell controls thickness of the ring, and
thus wall thickness of the final vessel. Completed tissue rings are then stacked to form a
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tubular, vascular graft via the RSM. The advantage to this method is that any adherent
cell type can be seeded into the plate setup and tissue rings or tubes of any size needed
for the desired application can be generated by simply modifying guide inserts. Comparative techniques in tissue engineering creating rings of tissue remain difficult to scale,
(Blakely et al., 2015; Gwyther et al., 2011) requiring remanufacture of molds for each
desired size. Additionally, vascular grafts made using this method can be produced in 23 weeks, several weeks faster compared to other engineered vessels.
Materials and Methods
Cell Culture Preparation
Utilize human aortic smooth muscle cells (SMCs), human endothelial cells (ECs)
and human dermal fibroblasts purchased commercially. Maintain SMCs in SMC growth
media composed of 88.6% 231 media, 0.1% each of recombinant human insulin (rHinsulin), recombinant human fibroblast growth factor (rH-FGF), recombinant human epidermal growth factor (rH-EGF), and ascorbic acid; and 5% each of fetal bovine serum
(FBS) and L- glutamine; and 1% antibiotic/antimycotic. Each growth factor, FBS and Lglutamine are purchased as a vascular media growth kit. ECs will be cultured in EC
growth media composed of 91.3% 131 media, 2% FBS, 5% L-glutamine, 0.1% ascorbic
acid, 0.1% recombinant human insulin-like growth factor (rH-IGF), 0.1% rH-FGF, 0.1%
rH-EGF, 0.1% heparin sulfate, 0.1% recombinant human vascular endothelial growth factor (rH-VEGF), and 0.1% hydrocortisone. Fibroblasts were maintained in fibroblasts
growth media composed of 89% Dulbecco’s Modified Eagle Medium (DMEM), 10% FBS
and 1% antibiotic/antimycotic. Change media every 48 hours until the cells are about 90%
confluent and ready for tissue seeding. Store cells in an incubator in between media
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changes for expansion.
Preparation of 3D Printed Inserts and Custom Silicone Molded Plates.
Use a commercial 3D printer (e.g., Replicator Mini) for 3D printing the plate inserts.
Use open source 3D design software such as Blender to create the 3D models of the
printed outer-shells and posts. Export the model’s driver file via a .stl format allowing for
portability to the 3D printer’s software. Produce printed posts and outer shells using poly
(lactic acid) filament (PLA) loaded into the 3D printer. Following printing, perform a 30minute soak in a 70% -100% ethanol solution to sterilize each insert. Prepare a 1:10
curing agent to base polymer mixture of poly(dimethylsiloxane) (PDMS) silicone polymer
and allow the mixture to degas at room temperature for 10 min. Define petri dish sizes
used as small (35 mm), intermediate (60 mm), and large (100 mm). Add 2 ml, 4 ml and
6 ml of uncured silicone to each small, intermediate and large plate, respectively, and
create a thin layer across the entire bottom of the petri dish. Create posts for the small
plate by pouring PDMS into a 100-mm plate to a height of 7 mm and allow to cure on a
hot plate at 60 °C for about 2-3 hours. Then use a 5-mm biopsy punch to punch out
cylindrical posts. Use a small amount of uncured PDMS to secure each PDMS cylinder
and to the center of each small plate. For the intermediate and large plates, prior to complete curing of the PDMS at the bottom of the plate, place the 3D printed posts 10 mm
and 20 mm in diameter centrally into each intermediate and large plates, respectively.
For the large plates, additionally place a 3D printed outer shell about 66.7 mm in diameter
equidistance from the post. Allow each dish to cure in open air on a hot plate at 60 °C for
about 2-3 hours, allowing 18 hours for degassing of the polymer. Fix printed components
to the plate in the proper region and orientation as seen in Figure 3-1. Add a solution of
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70% ethanol with 30% distilled water for 30 minutes to the inside of all plates for sterilization and then cover each plate. Carefully aspirate the ethanol from each plate and allow
to air dry. Arrange each plate in a biological safety cabinet (BSC) next to their lid, faceup. Expose plates and lids to UV light under the BSC for 30 minutes to complete sterilization. Sterile technique is performed with every step after UV exposure.
Preparation of Fibrin Hydrogel, Seeding with Smooth Muscle Cells and Maintenance of
Plates
Mix a solution of fibrin gel containing growth media + 0.01% TGF-b1 in the amounts
of 0.5 ml, 1.1 ml and 1.81 ml for small, intermediate and large plate sizes, respectively.
Add 40 µl, 88.4 µl and 145 µl of thrombin, from a stock of 100 U/ml, to the media of each
small, intermediate and large plate, respectively. Gently swirl each plate by hand to ensure that thrombin is evenly mixed within the media. Next, add 160 µl, 354 µl and 580 µl
fibrinogen, from a stock of 20 mg/ml, drop-wise circularly to the thrombin-media mixture
to each small, intermediate and large plate, respectively. Gently swirl by hand to ensure
mixing and distribution of the hydrogel into an even layer. Allow hydrogel to cure for 1015 minutes at room temperature. Trypsinize SMCs expanded in 150 mm cell culture
plates and centrifuge. The resulting pellet should be resuspended in 3 ml of differentiation
media consisting of 98% - 231 media, 1% FBS and 1% antibiotic/antimycotic. Vigorously
mix cells by titrating up and down with a 2-ml pipette to break up any cell clumps. Count
cells with a hemocytometer and create a cell suspension of 2 x 106 cells/ml, 1.0 x 107
cells/ml and 1.4 x 107 cells/ml for small, intermediate and large plates, respectively. Add
1 ml of each cell suspension into a corresponding 50 ml conical labelled small, intermediate and large. Set up an additional 50 ml conical in this manner for each additional
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tissue ring desired. Add differentiation media to each conical to obtain final seeding volumes of 2 ml, 4 ml and 5 ml for each small, intermediate and large vessel, respectively.
Then, carefully pipet the cell solution drop-wise on top of the prepared hydrogel in each
corresponding plate. Place plates into the incubator at 37°C and 5% CO2. Change differentiation media every 48-72 hours for each plate. In the case of the larger plate, change
media initially after 24 hours, then change it every 48-24 hours to compensate for the
large cell seeding density. After 2-4 days as the rings will have completely contracted in
towards the post, add 10 µl, 20 µl and 35 µl of TGF-b1 to each small, intermediate and
large ring, respectively. After exposure to TGF-b1 for at least 24 hours, rings are ready to
be handled.
Assembly of Vascular Construct and Maintenance
Before the fabrication of the final vascular construct, a specialized container is created to hold the completed vessel. For the small vessel, create a tall plate for ring stacking
by cutting a 2-inch section off the top of a 50-ml polycarbonate conical tube, and then
PDMS glue the cut edge into a 35-mm plate. Use the conical lid as the plate lid. For the
intermediate and large vessel, tall ring stacking plates, cut a 1.75-inch diameter polycarbonate tube into 2.5 inch sections lengthwise to serve as the tall plate walls. For the tall
plate bottoms, cut a 0.125-inch-thick polycarbonate sheet into 2-inch diameter circle
pieces. Using acrylic solvent cement, bind the polycarbonate tube section to the circular
cut piece. Use the lid from a 60-mm petri dish as the lid for the tall plate. 3D print posts 5,
10 and 20 mm in diameter and all 50 mm in length. Add 10 ml of uncured silicone to each
container. Prior to the complete curing of the PDMS, centrally place each post created in
step 4.1.3 into each small, intermediate, and large container. Allow to cure on a hot plate
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set to 60 °C for 2-3 hours. Sterilize with a solution of 70% ethanol with 30% distilled water
for 30 minutes. Carefully aspirate the ethanol from each container and then allow to air
dry in the BSC. Next, the containers were arranged in the hood with each plate placed
next to its lid, face-up. Expose containers to UV light under the BSC for an additional 30
minutes for further sterilization. Use sterile technique with every step after UV exposure.
Using very fine forceps, carefully remove each tightly rolled smooth muscle hydrogel ring
from its post and transfer to its corresponding larger container with the tall posts. Use a
pair of forceps in each hand and lift one side of the ring from the post, then the other. Be
careful to protect and maintain the lumen. Perform the transfer with this two-handed
method, sliding first one side, then the other side of the ring onto the tall post. Using
gentle, gradual movements, and working circumferentially, slowly push the ring down onto
the tall post. Subsequently stack tissue rings until the desired vessel length has been
obtained, with each ring adding approximately 1–2 mm of length to the completed construct. With the ring stack positioned on the tall 3D printed posts, turn the plate so that the
post is parallel with the working surface. Using a micropipette, add 40, 80 and 160 µl of
thrombin at a concentration of 100 U/ml gently to the outer surface of each small, intermediate and large vessel, respectively. While adding the thrombin, slowly rotate the plate
to ensure even coverage of all surfaces of the construct. This will be the base for the fibrin
glue utilized to secure the ring stack construct in the initial days after construction. Next,
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add 40, 80 and 160 µl of fibrinogen at a concentration of 20 mg/ml to each small, intermediate, and large construct, respectively, using a micropipette while rotating the construct quickly. The thrombin and fibrinogen quickly set into a firm gel once mixed. Due to
the short curing time, apply the fibrinogen as quickly and evenly as possible. Add 20 ml
of differentiation media to each container holding the construct. Place vessels into a 37
°C incubator until needed. Change media every 3-5 days.

Figure 3-1. A schematic with timeline of the scale up process (A). Small, intermediate, and large size rings
in corresponding plates (B). Different size engineered vessels increasing from left to right (C). Large engineered vessel on post removed from plate (D). (Pinnock et al., 2016)
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Results
Demonstrated here is fabrication of 3 different engineered vascular graft sizes
(Fig. 3-1), showing that the Ring Stacking Method (RSM) is scalable. To prove applicability, the 3 different vessel sizes chosen correlate to actual human vessel size for the left
anterior descending artery (small;
lumen diameter = 4 mm) (Fearon et
al., 2007), descending aorta (intermediate; lumen diameter = 10 mm)
and ascending aorta (large; lumen
diameter = 20 mm) (Erbel et al.,
2006). Wall thickness is about 500
μm for the small rings, and about
1500 μm for both the intermediate
and

large

rings.

Each

vessel

demonstrated is built by stacking 6
rings, equating to a length of approximately 6 mm for the small vessel and 9 mm for the intermediate

Figure 3-2. H & E and Trichrome stains. Small ring (top), intermediate ring (middle), and large ring (bottom). All rings
displayed a reasonable amount of cellularity. Trichrome images of the intermediate and large displayed globular collagen production seen in blue (blue arrow). (Pinnock et al.,
2016)

and large vessels. Length is based on the wall thickness of each individual ring.
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Figure 3-3. IHC stains. Various ring size increasing from top to bottom. Nuclei are stained blue via DAPI.
Components stained were smooth muscle a-actinin IV (red) and tropomyosin (green). Both are prominent
smooth muscle cell markers. (Pinnock et al., 2016)

Histological analysis revealed high cellularity in all rings sizes (Fig. 3-2). Red material demarcates fibrin gel. In small rings, a small amount of residual fibrin gel is seen on
the outer edge of the ring. In the larger rings, some fibrin gel was interspersed with the
cellular content. In the Masson’s Trichrome stain, indications of collagen production
(marked by blue) can be seen in the intermediate and large rings.

Table 3-1. Tensile Analysis. Properties such as elastic modulus, ultimate tensile strength all increased with
size. (Pinnock et al., 2016)
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Figure 3-4. Tensile Analysis. Stress-strain curves for each size individual ring and engineered vessel. (Pinnock
et al., 2016)

To determine cell phenotype following ring formation, tissue rings were analyzed
using immunofluorescence for antibodies to α-smooth muscle actin (SMA) and tropomyosin (Fig. 3-3). All ring sizes were positive for both antibodies, verifying smooth muscle
phenotype was maintained.
Tensile testing was performed on the different size rings to determine their mechanical properties (Fig. 3-4). The U-stretch, a mechanical testing device was used to
tensile test small and intermediate rings and vessels, while an Instron was used to tensile
test large rings and vessels. Elastic modulus (E), ultimate tensile
strength

(UTS)

and

failure

strength (FS) data were collected.
A consistent trend was observed
with increasing strength correlating to increasing ring and vessel
size.

Figure 3-5. Cell seeding number with respect surface area. 2
x 106 (small rings), 10 x 106 (intermediate rings), and 14 x 106
(large rings) cells are needed to seed each size engineered
vessel. (Pinnock et al., 2016)
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Cell seeding number needed for creating the varied sized rings increased approximately linearly with seeding surface area (Fig. 3-5). To create larger rings, at least 14
million cells were needed to create the abdominal aorta sized rings.
Six-ring stacks, or vessels, were tested for their ability to withstand flow. Constructs
were loaded into a custom-built perfusion system (Fig. 3-6) and subjected to flow for up
to 5 min at flow rates from 100 to 417 ml/min. Vessels could withstand flow. Minor leaking
was observed at the vessel ends, at the connectors to the perfusion system.

Figure 3-6. Open environment perfusion system set up (A). Small size engineered vessel (middle) re-establishing media flow from inflow tube to outflow tube (white arrows) (B). (Pinnock et al., 2016)

Discussion
The Ring Stacking Method presents multiple advantages over current vascular tissue engineered construct techniques. The RSM can be adapted to create human vessels
of any size by simply customizing the post and outer shell dimensions. Our method allows
for development of polymer-free engineered vessels composed solely of human cells and
rapidly degrading support material found in the body’s natural wound healing process.
Polymer grafts are known to cause restenosis in the clinic and could become problematic
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if contained in engineered grafts. Cell seeding number needs to be modified for each
different size tissue ring. A graph of the cell number to the seeding surface area is shown
in Figure 5 from which the seeding number can be approximated and/or extrapolated. It
should be noted that the cell type used here are human aortic smooth muscle cells. To
adapt the RSM to different cell types, cell size and proliferation rate need to be taken into
consideration and optimal seeding density determined. For example, we have also created human fibroblast rings using the RSM and have found that at least 2x the number of
cells is needed compared to SMCs. Any desired length of vessel can be built through the
addition of rings. Ring stacks have been cultured for up to 2 months and remained stable.
Intermediate and large rings are both kept at the appropriate 1500 μm wall thickness even
though they are each constructed in a 60 mm and 100 mm plate, respectively, by placement of an outer shell in the 100-mm plate. This shows the utility of the outer shell for
controlling and obtaining the appropriate wall thickness for a given vessel. TGF-β1 is
added because it is known to stimulate collagen production (Ha et al., 2016) and has the
observed effect of tightening the rings. Once the rings have completely rolled, one dose
of TGF-β1 is added in the final step, and the rings are ready for use 1 day later. TGF-β1
does enhance collagen production in the rings, as seen in the Trichrome images (Fig. 32).
Cells in the small rings are rounder and more compact, whereas in the 2 larger
sizes, cells along the outer edges display a degree of alignment with the tissue edge and
along with other aligned cells. The latter may indicate a later stage of cell maturity, evolved
from higher cell content in the larger rings, and hence more intercellular signaling to encourage maturity. Fibrin gel interspersion in larger rings may indicate that larger cell
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sheets tend to fold slightly as they roll. The histological images showing this phenomenon
were taken 1 day following complete ring roll up- thus it is understandable that the fibrin
gel, which takes 2 weeks to degrade in culture, would still be present. Culturing the rings
for at least 2 weeks should degrade the fibrin gel, leaving behind a fully cellular construct.
Alpha-smooth muscle actin (SMA) constitutes the thin filaments that facilitate contraction and tropomyosin is a contractile protein (Skalli et al., 1989; von der Ecken et al.,
2015). Both SMA and tropomyosin were present in all size rings, with the strongest, most
evenly distributed signal in the intermediate rings. This phenomenon may be due to more
cell density and organization, stimulating an increase in contractile operandi development.
Elastic modulus indicates the elasticity of the rings, and the increasing E from small
to large rings suggests an increase in collagen and elastin production. Ultimate tensile
strength is the highest strength endured by the rings without breaking. Failure strength is
the point of tissue failure. For the rings, UTS = FS. For the vessels, UTS > FS, which
shows that the ultimate strength of the vessel is attributed to the combination of mechanical contribution from all rings in the vessel, and the failure point is due to the weakest
ring.
The strength of our engineered vessels lay in the kPa range, whereas native human vessels have strengths within the MPa range. To strengthen our vessels towards
that of native vessels, we are investigating techniques to increase extracellular matrix
production, namely that of collagen and elastin. Growth factors that promote collagen and
elastin production are currently being applied to our rings to investigate whether tensile
properties will increase.
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In addition to mechanical properties, functional measures of muscle contraction
are relevant to vessel performance. Muscle stimulation and contraction by factors such
as acetylcholine and epinephrine can be used to test muscle contractile force. Such experiments are being considered for our future studies.
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CHAPTER 4 INDUCTION OF EALY STAGE ATHEROSCLEROSIS IN A SMALL TWO
CELL LAYER VESSEL WITH LATE STAGE CALCIFICATION COMPUTATIONAL
VALIDATION
The first chapter described the process of plaque formation attributed to atherosclerosis. Atherosclerosis is characterized by plaques which occlude the vessel and severely block blood flow as the disease progresses (Saez et al., 2014). Plaques are caused
by elevated low-density lipoprotein (LDL) in the blood, which initiates an immune response cascade leading to severe arterial stiffening due to calcification. Calcification is
the main factor affecting vessel mechanics in atherosclerosis. During disease progression, the smooth muscle cells located in the tunica media release calcium into the surrounding tissue, calcifying the plaques. Over time, the calcified plaques increase in size
leading to occlusion of the artery. There are two types of calcified plaques, defined by
their shape - concentric and eccentric (German et al., 2916). Concentric plaque formation
is a symmetric calcification and loss of compliancy along the arterial wall. Eccentric
plaque formation is an asymmetric calcification and loss of compliancy along the arterial
wall, where one side may have little to no stiffening at all. To better understand how to
construct a 3D tissue engineering disease model using a BEBV singular rings created via
the RSM, we must learn how create these pathological changes in vitro.
The first step towards creating an atherosclerosis disease model, one must mimic
the inflammation response associated with the illness. One study used a co-culture of
endothelial cells (ECs) and smooth muscle cells (SMCs) in along with monocytes to
achieve foam cell development (Takaku et al., 1999). The researchers plated a layer of
collagen, followed by a final seeding of ECs on top. They mixed ox-LDL into the collagen
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layer between the ECs, for it to act as the sub-endothelial space. They observed monocyte transmigration through the EC monolayer along with macrophage differentiation and
foam cell formation. A similar study discovered that adding a EC + collagen + SMC model
elicited increased monocyte transmigration (Navab et al., 1988). This was compared to a
collagen and EC + collagen model that relies on a chemoattractant for monocyte transmigration. Via transverse sections they witnessed numerous monocytes in the sub-endothelial space after adhesion to the EC monolayer. These two groups were able induce
monocyte transmigration using a Cartesian co-culture models but failed to create a fibrous
cap that is necessary for the occlusion of the vessel.
Computational simulations are a useful tool to validate experimental procedures
and results for benchtop models of arterial disease (He et al., 2017). Computed tomography (CT) images of existing artery networks explanted from a cadaver can be used to
create a 3-dimensional computer model (Kaski et al., 1991). Hemodynamics of an artery
can be modeled using a finite element analysis, under the assumptions that the system
is laminar, Newtonian, viscous, and has incompressible blood flow with a linear-elastic,
isotropic, and incompressible vessel wall (Boutsianis et al., 2004). Using the NavierStokes equations, the fluid dynamics can be calculated for flow and pressure through the
arteries in the presence of the concentric and eccentric occlusion models (Sun et al.,
2014). Due to the hyper-elastic nature of the collagen fibers in the extracellular matrix of
the arterial wall, the tissue will take on a non-linear behavior which can be mathematically
modeled using the Money-Rivlin equation (Karimi et al., 2017).
The aim of this chapter was to create a tissue engineered atherosclerotic calcification model correlated to a computer simulation and to begin early immune response
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model using smooth muscle cells, endothelial cells and monocytes in vitro. The main purpose of the computer simulation was to augment the data provided by the bench-top
engineered model to provide information beyond the capabilities of the engineered model.
Specifically, the engineered model was used to test application of calcification techniques
to an actual tissue model. Next, the computer simulation was used to validate the experimental calcification techniques, and then to model concentric and eccentric plaque formation. The computer simulation was able to be easily extended modeling capabilities
into an area challenging for the bench-top model to duplicate. The advantage our laboratory has is that we are able to readily correlate computer modelling with benchtop data
obtained from our lab’s completely biological engineered blood vessels (BEBVs) via the
RSM seen in chapter 2 and 3. Thus, we are able to collect the appropriate experimental
data to input into the simulation, greatly increasing the accuracy of our model compared
to common purely computational approaches.
To induce calcification into the BEBVs, calci-protein particles (CPPs) were explored. CPPs were identified as a promising candidate to induce calcification due to their
ability to stimulate calcium release by smooth muscle cells (SMCs) in vitro (Aghagolzadeh
et al., 2016, Kelynack et al., 2016). Additionally, high CPP levels can be found in patients
suffering from CAD (Nakazato et al., 2016). CPPs are also present clinically in chronic
kidney disease (CKD) patients, which correlates with a high incidence of atherosclerosis
(Zeper et al., 2019). The CPPs were able to be successfully integrated into the BEBVs.
CPP-integrated BEBVs were uniaxially tensile tested to determine resultant stiffness.
The conditions found in the experimental BEBV model were further iterated in a
cylindrical computational model of the pathology of atherosclerosis to establish optimal

53
experimental parameters of the calcification process. Following the generation of a CPPcontaining BEBV, a 3-dimensional simulation model of the engineered vessel was generated in a non-linear, hyper-elastic laminar flow simulation using ANSYS. Next, both
concentric plaque buildup with 75% occlusion and eccentric plaque buildup with 75% occlusion was created to better understand the efficacy of the CPPs to simulate an occluded
state. This work shows that computer simulations can serve as a valuable tool to verify,
iterate and further augment pathophysiological processes applied to benchtop models. In
this specific case, a computer simulation was used to improve an engineered model of
atherosclerosis being developed to, in the future, test new disease treatments.
Following the computer simulated calcification model, we will combine those tissue
creating methods using CPPs to create an initial in vitro tissue engineered atherosclerotic
disease model using singular rings and a BEBV with two cell layers (intima and media).
THP-1 monocytes will be cultured and used because they are highly characterized for
atherosclerosis studies in vitro (Graham et al., 1996, Hayden et al., 2002). During the
inflammation response that initiates atherosclerosis monocytes differentiates into M0 then
into either M1 or M2 macrophages (Bobryshev et al., 2016). M1 macrophages are proinflammatory cells that further promote the recruitment of monocytes (Yang et al., 2014).
M2 macrophages are anti-inflammatory cells that inhibit the further recruitment of the
monocytes (Ley et al., 2017). Even though both M1 and M2 macrophages are present in
plaque formations M1 macrophages and endothelial cells responsible for recruiting more
monocytes. ox-LDLs will be present in our tissues to better mimic the disease state. We
will determine the mechanical properties of the engineered diseased tissue later in the
chapter.
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Materials and Methods
Cell culture
The cells utilized were human aortic smooth muscle cells (SMCs) and purchased
from American Type Culture Collection (ATCC) (PCS 100-012, ATCC, VA). The cells
were maintained in smooth muscle cell growth medium consisting of 88.6% Dulbeccos
Modified Eagle Medium (SH30022.01, Hyclone Laboratories, UT); 0.1% each of recombinant human insulin (rH-insulin) (407709-50MG, EMD Millipore, Darmstadt, Germany),
recombinant human fibroblast growth factor (rH-FGF) (100-18B, Peperotech, NJ), recombinant human epidermal growth factor (rH-EGF) (AF-100-15, Peprotech, NJ), ascorbic
acid (A-7506, Sigma-Aldrich, MO); and 5% each of fetal bovine serum (FBS) (10437-028,
Gibco, MA) and L-glutamine (BP379-100, Fisher Scientific, NJ); and 1% antibiotic/antimycotic (15240-0621, Gibco, MA). The medium was changed twice a week until the cells
were ready to be seeded into engineered vascular rings as described further within. THP1 cells were purchased from ATCC and maintained THP-1 growth medium consisting of
88.6% RPMI Medium (SH3002701, Hyclone Laboratoris, UT); 10% FBS and 1% antibiotic/antimycotic. Media for the THP-1 was changed every 3 days. HUVECs will be cultured in EC growth media composed of 91.3% 131 media, 2% FBS, 5% L-glutamine,
0.1% ascorbic acid, 0.1% recombinant human insulin-like growth factor (rH-IGF), 0.1%
rH-FGF, 0.1% rH-EGF, 0.1% heparin sulfate, 0.1% recombinant human vascular endothelial growth factor (rH-VEGF), and 0.1% hydrocortisone. The media was changed every
3 days.
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Preparation of calci-protein particles (CPPs)
The CPPs were produced under sterile conditions by mixing 15 ml FBS; 30 ml of
20 mM CaCl2 (C1016-500G, Sigma-Aldrich, MO) in tris-buffered saline (TBS) (BP1757500, Fisher Scientific, NJ); 30 ml of 14 mM NaHPO4 (S9638-500G, Sigma-Aldrich, MO)
in TBS; and 45 ml SMC growth medium in a 100 ml sterile specimen bottle. Utilizing a
magnetic stir bar and plate, the solution was continually mixed slowly for 12 hours at room
temperature. The solution was then aliquoted into three 50 ml tubes pipetting 40 ml of
solution into each. The solution was centrifuged at 5000 rpm for 10 hours at 4°C. Following centrifugation, the supernatant was removed, and each pellet resuspended in 2 ml of
SMC growth medium warmed to 37°C creating a CPP suspension. The CPP solution can
be stored at 4°C for 2 months.
Preparation of plates for the engineered vessels
As described further herein, ring structures are created out of vascular cells then
stacked to generate our engineered vessels, by the RSM. To create the ring structures,
vascular cells were plated in custom-made plates with a central post around which the
rings would form (herein termed the post plates). To make these plates, first, a 1:10 curing
agent base polymer mixture of poly(dimethylsiloxane) (PDMS) silicone elastomer (Sylgard 184, 1064291, Dow Corning Co, MI) was prepared. Two ml of uncured silicone was
added to each well of 6-well petri dish. The 6-well petri dish was placed on a level surface
and allowed to initially cure for 2 hours uncovered. Next, the petri dish was placed on a
hot plate set at 60°C for 3 hours uncovered to complete curing of the silicone polymer.
Posts were created by pouring PDMS into a 100 mm petri dish at a height of 7 mm and
allow to cure on a hot plate at 60°C for about 3 hours to generate a bulk piece of PDMS.
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Next, a 5 mm biopsy punch (33-35, Miltex, PA) was used to punch out cylindrical posts
to create 5 mm diameter lumen rings. A small amount of uncured PDMS was applied to
the bottom of each PDMS cylinder to attach it to the center of each well. The 6-well petri
dish was placed on the hot plate at 60°C for 3 hours until cured. In a biological hood, a
solution of 70% ethanol (2705, Decon Laboratories, PA) with distilled water (W5-4, Fisher
Scientific, NJ) was added for 30 minutes to the inside of each well for sterilization. Then
the ethanol was carefully aspirated from each well. Next, the dishes were exposed to UV
light under the hood for an additional 30 minutes for further sterilization.
Seeding cells for forming vascular rings
To form the vascular ring structures, human aortic SMCs were seeded into the
post plates along with a fibrin hydrogel which served as a provisional, temporary matrix
to stabilize the cell monolayer. An SMC cell suspension of 1.5 x 106 cells/ml was created
for seeding cells on top of the hydrogel. Cells at a concentration of 1.5 x 106 cells/ml were
resuspended in a solution of 20 mg/ml of fibrinogen (MP Biomedicals, CA) for adding cells
inside the hydrogel. Rings were divided into two groups: the non-treated (control) and
CPP (experimental) group. Hydrogel medium was defined as SMC growth medium with
0.01% TGF-b1.
To form the rings, first, 160 µl of fibrinogen with a 1.5 x 106 cell suspension the
fibrinogen was added to the 6-wells with and without CPPs (experimental and control
groups, respectively), followed by 40 µl of thrombin from a stock of 100 U/ml (7592, Biovision, CA) to create the fibrin gel. The hydrogel was allowed to cure for 5-10 minutes at
room temperature in the biological hood. For the CPP group, 25 µl of suspended CPP
solution was added to each well and swirled for equal distribution. No CPPs were added
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to the wells for the control group. Next, 1.5 x 106 cells in 1 ml of SMC growth medium was
added in a circular motion to each well for both groups for seeding cells on top of the
hydrogel. Lids were placed on the plates and placed in the incubator. After 12 hours, the
medium was aspirated and replaced with 2 ml of fresh SMC medium. For the CPP group,
50 µl of the CPP suspension was added to each well. The medium was changed every
48 hour and fresh CPP solution added to each well during each media change for 7 days.
For all groups, after 3-5 d, rings fully aggregated in towards the post forming the ring
structures, following this 10 µl of TGF-b1 was added to each well for both groups.
Stacking of Rings into Engineered Blood Vessels (Ring Stacking Method)
To hold the BEBV, a specialized container called a “tall plate” was made using
polycarbonate tubing, 60 mm petri dish bottom and lid. The two pieces were adhered
together using a polymer solvent. A ring stacking post 5 mm in diameter and 30 mm long
was 3D printed (MakerBot, Brooklyn, NY) with a poly(lactic acid) (PLA) filament. Following
this, 8 ml of uncured PDMS was added to the tall plate, then the 3D printed ring stacking
post were placed in the center of the plate. PDMS in the tall plates was allowed to degas
at room temperature for 2 h then placed onto a hot plate at 60°C for 2-3 h to cure. A
solution of 70% ethanol was added for 30 min to the inside of each tall plate to sterilize.
The ethanol was aspirated, and the tall plates exposed to UV light under the hood for 30
minutes to finalize sterilization. Using very fine forceps, each engineered ring was carefully taken from its post and transferred to the stacking post of the tall plate. Each ring
was gently moved circumferentially down to the bottom of the post. Six rings were stacked
to constitute one engineered vessel. With the ring stack on the stacking post, the tall plate
was then turned so that the post was parallel to the working surface. Using a micropipette,
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40 µl of thrombin at a concentration of 100 U/ml was gently applied to the ring stack using
a rotating motion. Next, 40 µl of 20 mg/ml concentration fibrinogen was added to each
ring stack using a quick, rotating motion. The thrombin and fibrinogen quickly cured to
form a firm gel once mixed, hence coating the entire BEBV with a thin layer of fibrin gel
in the final step. Twenty ml of SMC growth medium was added to the tall plate holding
the engineered vessel and placed into the incubator. Media was changed every 5-7 days
until use.
Human Tissue Controls
Human common iliac arteries (CIA) were isolated and donated from a patient with
unknown age and sex who underwent an extraction their abdominal aorta-common iliac
artery bifurcation due to extreme calcification and occlusion of the abdominal aorta and
right CIA by way of the Vascular Surgery Clinic at Henry Ford Hospital (Detroit, MI). This
tissue was used as control tissue for normal and calcified states in order to determine to
obtain elastic moduli ratios through tensile tests.
Creation of Diseased Tissues Rings for Atherosclerotic In Vitro Model
Diseased tissue rings were created in two methods: natural disease rings (ND) and
engineered disease media rings (EDM). Natural disease rings were created in same manner as the control and CPP rings above accept 1.5 x 106 SMCs were suspended in 340
µl of SMC growth medium instead of fibrinogen. 160 ul of Ox-LDLs was to mimic oxLDLs
that have fallen in the subendothelial space. Then 40 µl of thrombin followed by 160 µl of
fibrinogen to cure the hydrogel and cells. Following this 1 .5 x 106 SMCs were seeding on
top with 1 ml of SMC growth medium. Rings formed after about 1 week in culture and
media changes were provided similar to the above protocol and previous chapters.
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EDM rings were created in the same manner as the natural disease except 1 x 106
THP-1 undifferentiated cells were added via a 50 µl suspension in THP-1 growth medium
was added to the hydrogel medium along with the SMCs and ox-LDLs. This was followed
by an addition of 25 µl of CPPs to the hydrogel. Media changed in the same manner as
the CPP ring protocol previously described.
Creation of Disease Vessels and In Vitro Atherosclerotic Disease Model
Diseased vessels were created from the ND rings only containing ox-LDLs and
SMCs. This done via the RSM and in the same method as described earlier. These ND
BEBV were cultured for 2 weeks at 37 ºC in an incubator in SMC growth medium. Then
the intima layer of the ND BEBV was statically and dynamically seeded with HUVECs in
the same manner as seen in Chapter 2. After intima seeding the ND BEBV the PSOS +
fitting + ND BEBV was placed back in the static seeding plate. Following this 1.5 x 107
THP-1 (3 x 150 mm plates) were centrifuged at 130 rpm for 10 minutes then resuspended
in 600 µl of THP-1 growth medium. Then add the THP-1 to M1 differentiation reagents: 1
µl of 10 ng/ml phorbol 12-myristate 13-acetate (PMA), 3 ul of 100 µg/ml lipopolysaccharide (LPS), and 24 µl of 20 ng/ml interferon-gamma (IFN-gamma) to the cell suspension
(Morón-Calvente et al., 2018). Carefully via pipette the THP-1 suspension into the PSOS
+ fitting + ND vessel. After incubation at 37 ºC for 24 hours carefully aspirate the media
and cells and prepare another THP-1 suspension in 500 µl THP-1 growth medium + differentiation reagents. This time add 100 µl of CPPs, 1 µl of FGF and 1µl of PDGF to the
cell suspension. Then carefully pipette the THP-1 suspension into the static system. Following this rotate the PSOS + fitting + ND BEBV 120º. After 24 hours of incubation, carefully aspirate the cells and media and carefully pipette another THP-1 suspension in 600
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µl THP-1 growth medium + differentiation reagents + 150 µl CPPs + 1 µl of FGF and
PDGF. Rotate another 120º then incubate for at 37 ºC for 24 hours. Following this carefully aspirate and prepare ND vessel for histology.
Tensile Testing
Tensile testing of all in vitro tissue samples was performed on a Cellscale uniaxial
stretch device (Cellscale, Montreal, Canada). The strain rate was set to 0.4 mm/s. Samples were loaded into the Cellscale using custom steel hooks. Sandpaper was adhered
to a piece of foam to create grip pads which were then attached to the steel hooks. The
samples were looped around the hooks before stretching. These grips were used for all
groups: normal human vessel (n=1); calcified human vessel (n=1); engineered vascular
rings (n=5); CPP-treated rings (n=5); normal engineered vessels (n=6); CPP-treated engineered vessels (n=5); and in vitro EDM rings. Following loading, the initial length, thickness and lumen diameter of each sample was measured using calipers for force, stress
and strain calculations. All groups were circumferentially stretched until failure.
Histology
ND BEBVs and EDM rings were fresh fixed into optimal cutting temperature (OCT)
compound, cryosectioned into 10 ml cross-sectional sections, mounted onto slides, and
air-dried overnight prior to staining. Samples were stained with hematoxylin and eosin
(H&E), Von Kossa Stain and Oil Red O Stain. In H&E stained samples, the purplish structures shown indicate cell nuclei, while pink regions indicate cytoplasm and residual fibrin
gel. The Von Kossa stained samples, the nuclei are stained red, the light pink regions
indicate the cytoplasm and calcium deposited stain brown black. In the O Red O stained
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samples, the purplish structures are the nuclei and any oil or lipids present in the sample
stain red.
Statistics
All averages are reported as mean values ± standard deviation. ANOVA with
Tukey post hoc test was performed for tensile data comparison with EDM rings. Student’s
T test was run on control vs CPP group tensile and simulation data. Alpha value for significance was set to 0.05.
Mathematical Model
Model Geometry and Material Properties
The software package used to create the computational model was ANSYS 19.
The geometry for the mathematical model was a straight, three-dimensional cylinder with
dimensions based on the engineered vessel size applicable to the clinic. An inlet and
outlet were added to the simulation to accurately replicate the flow pattern through the
BEBVs in our custom perfusion testing system. The cylinder was set to 42 mm long in the
z direction with three tube segments composed of a 15 mm long inlet silicone tube, a 12
mm long BEBV and a 15 mm long outlet silicone tube. Both the silicone tubes had an
inner diameter of 5 mm and a thickness of 0.5 mm. The BEBV had a lumen diameter of
5 mm and vessel wall thickness of 1 mm. In the computer model, the silicone tubes were
represented as linear anisotropic materials and the BEBV was represented as a hyperelastic material.
Numerical Model for Fluid-Structure Interaction (FSI) Simulation
For the computational model, assumptions were set for a laminar, incompressible,
Newtonian flow. Thus, the governing equation is a simplified derivation of the Navier-
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Stokes equation for a velocity profile in the y direction (Eq 4-1) which was integrated by
parts to obtain equation (Eq. 4-2):
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Equation 4-1.

Equation 4-2.

where 𝑟 is the radius, 𝑑𝑃 is the pressure drop across 𝑑𝑦, and 𝜇 is the viscosity of blood
(𝜇 = 0.0035 𝑃𝑎 ∙ 𝑠). Since flow is equivalent to the product of the cross-sectional area and
velocity, flow through the blood vessel can be defined as:
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Equation 4-3.

This equation is the Hagen-Poiseuille equation for fluid flow in a tube which approximates
blood flow through an artery. To determine whether the flow is laminar or turbulent, the
Reynolds Number of the system needs to be calculated by this equation:

𝑅𝑒 =

𝜌𝑣2𝑟
𝜇

Equation 4-4.

./

where 𝜌 is the density of blood (𝜌 = 1060 0# ). To calculate the wall shear stress of the
BEBV, the equation of continuity (Eq. 4-5) and equation of motion for an incompressible
fluid (Eq. 4-6) must be evaluated in a cylindrical space:
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Equation 4-6.

The arbitrary values go to zero, leaving the simplified equation for the wall shear stress
of an artery as:

𝜏!+ =

𝑑𝑃𝑟
2𝑦

Equation 4-7.

Deformations of the BEBV was modeled using a three-term (Eq. 4-8) and five-term
(Eq. 4-9) Mooney-Rivlin equation:

𝑊 = 𝐶', (𝐼'̅ − 3) + 𝐶,' (𝐼-̅ − 3) + 𝐶'' (𝐼'̅ − 3)(𝐼-̅ − 3) + 𝐷(𝐽 − 1)𝑊 = 𝐶', (𝐼'̅ − 3) + 𝐶,' (𝐼-̅ − 3) + 𝐶-, (𝐼'̅ − 3)- + 𝐶,' (𝐼-̅ − 3)+ 𝐶'' (𝐼'̅ − 3)(𝐼-̅ − 3) + 𝐷(𝐽 − 1)

-

Equation 4-8.
Equation 4-9.

where 𝑊is the strain energy density; 𝐶', , 𝐶,' , 𝐶'' , 𝐶-, are material constants related to
distortional response; 𝐷 is the material constant related to the volumetric response; and
𝐼'̅ , 𝐼-̅ are the first and second invariants as described by:
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𝐼'̅ = 𝜆'- + 𝜆-- + 𝜆-2

Equation 4-10.

𝐼-̅ = 𝜆'- 𝜆-- + 𝜆-- 𝜆-2 + 𝜆'- 𝜆-2

Equation 4-11.

𝐼2̅ = 𝜆'- 𝜆-- 𝜆-2 = 𝐽-

Equation 4-12.

where 𝜆' , 𝜆- , 𝜆2 are stretch ratios and 𝐽 is the Jacobian determinant. The experimental
uniaxial tensile data for the control and CPP BEBV groups was used to create a curve fit
that was solved computationally to obtain the material constants. The radial deformation
of the control and CPP BEBVs under normal and occluded states was then compared.
The algorithm for the equations for the fluid, structural and re-meshing factors was
solved in a stepwise, coupled sequence. Convergence was determined using the Arbitrary Lagrangian-Eulerian (ALE) formula at each 0.05 s time-step increment for a time
period of 1 s. The calculations were performed with respect to time at various distances
y along the entire length of the vessel.
Boundary Conditions
A time-dependent, non-linear velocity profile at the inlet was created based on the
flow capabilities of the peristaltic pump (Longer Precision Pump Co., Ltd, Tucson, AZ)
being used to collect the experimental data:

𝑣3456" = 𝑣8908 [1 − cos(4𝜋𝑡)]

Equation 4-13.

where 𝑣 is the flow velocity of the pump (𝑣8908 = 0.0852 𝑚/𝑠). The period of the flow
waveform T was 1 s. Fluid velocity in the y direction was zero at the walls of the BEBV
and silicone tube, where r = 0 at the center of the tube and r = R at the wall. The velocity
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of the fluid described in Equation 4-2 holds along length y with respect to the radius of
the tube. The pressure inlet was set to zero. The pressure at the outlet of the tube was
defined as:

𝑃:9"56" = 𝑃8908 + ∆𝑃
∆𝑃 = −∆𝑦[

8𝜇𝑣8908
2
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3
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Equation 4-14.
Equation 4-15.

Equation 4-16.

Where ∆𝑦 is the length of the vessel (0.042 m), 𝑟;6<<65 is the radius of the lumen of the
vessel (0.0025 m), 𝑃8908 is the pressure of the peristaltic pump (500 Pa) and the expression for ∆𝑃 is derived from a non-linear pressure gradient equation (Chakravarty et al.,
1996, Zaman et. al., 2016). The wall shear stress is maximum where r = R and zero where
r = 0. The BEBV and silicone tube were fixed at both ends.
Model Validation
The mathematical model was validated using the ANSYS 19 workbench by means
of a Computational Fluid Dynamics (CFD) method. A system coupled computational FSI
simulation was created via the Transient Structural and Fluent toolboxes. The Transient
Structural toolbox validated the Mooney-Rivlin equations (8) and (9) using experimental
tensile data for both the control and CPP BEBVs. The Fluent toolbox validated the hemodynamic equations, and the nonlinear derivations for the bioreactor pump inlet velocity
and outlet pressure. Those same nonlinear equations for the inlet velocity and outlet pressure were written in C as a script and compiled into a user defined function (UDF) in order
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to be utilized by the CFD simulation in Fluent. Via toolboxes the mathematical model was
run for a period 1 s at 20 timesteps in increments of 0.05s. Although there are 20
timesteps data will be analyzed at timesteps 0.25 s, 0.5 s, 0.75 s and 1 s. Timesteps 0.25

Figure 4-1. Diagram showing the BEBV setup in the perfusion system which was mimicked in the
computer model (A). The BEBV was 12 mm, and the length of the silicone inlet and outlet tubes were
15 mm, for a total length of 42 mm. Control (B) and CPP (C) engineered rings are shown. Control (D)
and CPP (E) BEBVs shown inside of a tall plate. (Scalebar = 42 mm) (Pinnock et al., 2020)

s and 7.5 s will represent the peak values due to those times being the highest values
inside the period. Also, timesteps 0.5 s and 1.0 s represent the lower values due to those
times being the lowest values inside with the period.
Results
Establishment of the BEBV 3D computer model and tissue model
A diagram of the 3-dimensional computer model is provided in Figure 4-1A. A 3D
virtual representation of the silicone inlet and outlet tubes as well as the BEBV were created using the 3-dimensional software SpaceClaim (SapceClaim Corporation, Concord,
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Massachusetts). Smooth muscle cell tissue engineered rings were able to form successfully with the addition of CPPs and is shown alongside control rings without CPPs (Fig.
4-1B and C). Both control and CPP groups were successfully stacked into BEBVs in tall
plates (Fig. 4-1D and E). The addition of CPPs into the BEBVs did not change the macroscopic appearance compared to control engineered vessels.
CPP Calcification Significantly Affects Engineered Vascular Ring Mechanical Properties
Tensile results from the control (n=5) and CPP (n=5) tissue rings are shown in
Figure 4-2. Control and CPP group tensile data comparison is provided in Figure 4-2A,
where the peak force is 59.8 ± 8.64 mN and 76.6 ± 10.1 mN respectively. To obtain stressstrain curves, applied force was divided by the cross-sectional areas for the control and
CPP tissue rings, which were 3.02 ± 0.200 mm2 and 2.92 ± 0.133 mm2, respectively (Fig.
4-2B). A comparison of the elastic modulus is exhibited in Figure 4-2C. The elastic modulus was 6.71 ± 1.88 kPa for the control group and 13.3 ± 1.81 kPa for the CPP group,
which showed statistical significance (p<0.001). A comparison of the ultimate tensile
strength of both groups is shown in Figure 4-2D. Addition of the CPPs, i.e. calcification
of the engineered vascular tissue, significantly increased ultimate tensile strength from
20.0 ± 1.86 kPa in the control group to 26.3 ± 4.19 kPa in the CPP group (p < 0.05). A
comparison of the strain at failure is provided in Figure 4-2E. The strain at failure was
362 ± 66.8% for the control group and 214 ± 18.0% for the CPP group, resulting in a
significant decrease (p<0.01) in the strain at failure for the CPP group compared to the
control. In Figure 4-2F a comparison of the stiffness is shown. The stiffness was 4.55 ±
0.74 N/m for the control group and 7.56 ± 1.16 N/m for the CPP group. The mechanical
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data showed that addition of CPPs to the engineered vascular rings significantly increased elastic modulus and tensile strength, and decreased failure strength, which are
indicative of a calcified state.
CPP Calcification Significantly Affects BEBV Mechanical Properties
Tensile results from the control (n=6) and CPP (n=5) BEBVs are shown in Figure
4-3. Control and CPP group tensile data is shown in Figure 4-3A, with the peak force as
322 ± 32.0 mN and 406 ± 48.0 mN respectively. Average cross-sectional areas for the
control and CPP BEBVs were 13.7 ± 0.330 mm2 and 13.8 ± 0.130 mm2, respectively. The
associated stress-strain curves from the force and cross-sectional area data is shown in
Figure 4-3B. The elastic modulus was 12.1 ± 1.23 kPa for the control group and 16.2 ±
1.56 kPa for the CPP group (Fig. 4-3C). These results showed a significant increase
(p<0.001) in elastic modulus for the CPP group compared to the control (Fig. 4-3D). The
ultimate tensile strength was 23.6 ± 2.15 kPa for the control group and 29.6 ± 3.40 kPa
for the CPP group (Fig. 4-3E). These results showed a significant increase (p<0.01) in
the ultimate tensile strength by the addition of CPPs and hence calcification. The strain
at failure was 425 ± 71.0 % for the control group and 460 ± 51.9 % for the CPP group,
which showed no significant change in the strain at failure between groups. In Figure 43F a comparison of the stiffness is displayed. The stiffness was 23.07 ± 4.33 N/m for the
control group and 28.43 ± 3.95 for the CPP group. The mechanical data showed that the
CPPs were successful in modifying the engineered vessels (BEBVs) tensile properties
indicative of calcification.
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Normal and Diseased Human Common Iliac Artery Mechanical Properties
Human artery tensile mechanics serves as a method to compare whether our stiffness trends observed after the addition of calci-protein particles (CPPs) into our engineered tissues are appropirate. In one study the elastic modulus of common carotid arteries (CCA) from three healthy individuals was measured in vivo (Khamdaeng et al.,

Figure 4-2. Uniaxial tensile results for the engineered vascular rings. A) Control (blue; n=5) and CPP
(orange; n=5) ring force-displacement results show 59.8 ± 8.64 mN and 76.6 ± 10.1 mN respectively.
B) Control (blue) and CPP (orange) ring stress-strain data showing a steeper linear region for the CPP
compared to the control. Comparison of C) elastic modulus, D) ultimate tensile strength, E) failure
strain, and F) stiffness for both groups showing 6.71 ± 1.88 kPa, 20.0 ± 1.86 kPa, 362 ± 66.8%, and
4.55 ± 0.74 N/m for the control group, and 13.3 ± 1.81 kPa, 26.3 ± 4.19 kPa, 214 ± 18.0%, and 7.56
± 1.16 N/m for the CPP group respectively. (* p<0.05, ** p<0.01, *** p<0.001) (Pinnock et al., 2020)

2012). The in vivo elastic moduli values were 150 ± 40 kPa, 890 ± 270 kPa, and 750 ±
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kPa. Brachial blood pressure was measured from the individuals using a sphygmomanometer and the CCA pressure waveform was obtained using a sensor perpendicular to
the CCA. They were able to calculate the circumferential stress and strain using experimental values of the inner pressure and diameter of the CCA wall. A study applied a cyclic
method of tensile testing analysis where healthy common iliac artery (CIA) samples were

Figure 4-3. Uniaxial tensile results for the engineered BEBV vessels. A) Control (blue; n=5) and
CPP (orange; n=5) BEBV force-displacement results show 322 ± 32.0 mN and 406 ± 48.0 mN
respectively. B) Control (blue) and CPP (orange) BEBV stress-strain data showing similarly to the
CPP rings the CPP BEBV group displays a steeper linear region compared to that of the control
BEBV. Comparison of C) elastic modulus, D) ultimate tensile strength, E) failure strain, and F) stiffness for both groups showing 12.1 ± 1.23 kPa, 23.6 ± 2.15 kPa, 425 ± 71.0 %, and 23.07 ± 4.33
N/m for the control group, and 16.2 ± 1.56 kPa, 29.6 ± 3.40 kPa, 460 ± 51.9 %, and 28.43 ± 3.95
for the CPP group respectively . (* p<0.05, ** p<0.01)
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preconditioned with a load of 0.05 N for ten cycles (Faturechi et al., 2019). Then the tissues were stretched until failure with a stain rate of 1%/min. Another study extracted
healthy (n=8) and atherosclerotic (n=8) human coronary arteries (CA) from deceased patients ranging from different ages and conditions (Karimi et al., 2016). They found that in
both circumferential and axial stretch directions the elastic modulus and maximum stress
of the atherosclerotic group was significantly higher than the healthy group (p < 0.005).

Figure 4-4. Uniaxial tensile test results for the human Common Iliac Artery (CIA) for a normal (n=1)
and a diseased atherosclerotic (n=1) vessel. Force-displacement curves showing 15.3 N and of 0.949
N respectively (A). Stress-strain curves showing low ultimate tensile stress but steeper linear region
in the atherosclerotic group compared to the control (B). Elastic modulus (C), ultimate tensile strength
(D), failure strain (E), and stiffness (F) for both groups showing 148 kPa, 598 kPa, 514%, and 512.53
N/m for the normal CIA, and 230 kPa, 70.3 kPa, 52.2 %, and 856.36 N/m. (Pinnock et al., 2020)
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This study underwent tensile testing most identical to our own therefore we will compare
it to our human common iliac artery tensile data.
Tensile testing results for human common iliac artery (CIA) in normal (n=1) and
atherosclerotic (n=1) states are shown in Figure 4-4. The elastic modulus was 148 kPa
for the normal CIA and is 230 kPa for the atherosclerotic CIA (Fig. 4-4C). These results
show an increase in the elastic modulus of the atherosclerotic CIA compared to the normal CIA. When comparing to the elastic moduli from Karimi et al., we noticed our values
were lower, but the trend of the atherosclerotic group having greater value was the same.
The ultimate tensile strength was 598 kPa for a normal CIA and 70.3 kPa for the atherosclerotic CIA (Fig. 4-4D). These results show that the ultimate tensile strength of an atherosclerotic CIA is about 8.5 times lower that of a normal CIA. On the other hand, in Karimi
et al., we notice the ultimate tensile stress for the atherosclerotic group was larger almost
4 times larger than the healthy group. This could be due to either the severity of the CIA
we tested compared to the CA the study tested. Another reason could be the way the
samples were extracted. Karimi et al., perhaps had higher quality and precision surgical
equipment which led to them keeping the tissues and calcification in intact exceptionally.
Also, to note the size of the CA could have been different from the CIA we utilized, but
the manuscript does not list the nor state this information. On a whole after comparing the
two data it appears that human atherosclerotic tissue has a trend of having a higher elastic modulus compared to normal or healthy tissue.
Computer Simulated BEBV Hemodynamic Properties
A simulation on flow velocity through the control and CPP BEBVs was created using
our laboratory’s perfusion bioreactor as a basis to normalize experimental and simulation
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parameters (Fig. 4-5). The normal control and CPP group velocity profiles approximated
at the center of the BEBV were obtained at timesteps 0.25 s, and 0.5 s (Fig. 4-5A and
B). Profiles of both groups were laminar with maximum and larger velocities toward the
center of the BEBVs. Results at 0.25 s represent the peak velocity of non-linear pulsatile
flow, which is apparent due to the larger number of the higher velocities (Fig. 4-5, red
regions) in the center of the BEBVs. Alternatively, 0.5 s represent the lower velocity of the
non-linear pulsatile flow, also noticeable due to the lower number of higher velocities.
Concentric occlusion of the control and CPP group velocity profiles at the center of the

Figure 4-5. Cross-section at 21 mm (middle of the 42 mm long bioreactor setup) at times of 0.25s,
and 0.5s representing the peak and lower velocities respectively. Control (A) and CPP (B) BEBV flow
velocity profiles under normal conditions. On the other hand, Control (C) and CPP (D) BEBV flow
velocity profiles under 75% concentric occlusion conditions (dashed outline) where the average velocities appear to have increased due to the plague build-up. Control (E) and, CPP (F) BEBV flow
velocities under 75 % eccentric occlusion conditions (dashed outline) average velocities have increased compared to the normal conditions flow profiles. (Scalebar = 3 mm) (Pinnock et al., 2020)
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BEBV were simulated (Fig. 4-5C and D). The profile radius of the concentric state is
severely reduced while the lumen remains center. When observing profiles at 0.25 s, the
flow appears less laminar due to the overabundance of high velocities. Results at the

Figure 4-6. A graph comparing the average velocities of the normal control (solid blue) and normal
CPP (dashed orange) BEBVs at timesteps 0.25, 0.5, 0.75 and 1 s (A). Average velocities by time
graph comparing concentric occlusion control (solid blue) and CPP (dashed orange) BEBVs (B).
There is a significant increase in the average velocity at the peak timesteps for the CPP group. A
graph comparing the average velocities of the eccentric occlusion control (solid blue) and CPP (solid
blue) groups (C). This graph shows a slightly higher but not significant change in the velocity in the
CPP group compared to the control group. A bar graph comparing the absolute mean difference of
the average at maximum time points for the normal, eccentric occlusion and concentric occlusion to
further show the difference between the control and CPP group for each condition (D). Comparison
of the Reynolds number at different times for the normal control, normal CPP, eccentric occlusion
control, eccentric occlusion CPP, concentric occlusion control and concentric occlusion CPP (E). (*
p<0.05) (Pinnock et al., 2020)
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lower timestep appear to be laminar due to the reduction of flow. Eccentric occlusion of
the control and CPP group velocity profiles at the center of the BEBV were observed at
the same timesteps as the normal state (Fig. 4-5E and F). The profile radius of the eccentric state is severely reduced with the lumen shifted left from the center. When observing profiles at 0.25 s the flow appears less laminar due to the overabundance of high
velocities. Results from the lower timestep appear to be laminar due to the reduction of
flow.
A graph of the average velocities at timesteps 0.25 s, 0.5 s, 0.75 s, and 1 s for the
normal state control and CPP groups is shown in Figure 4-6A. Lower velocities (at 0.5 s
and 1 s) were similar with no significant difference. Peak velocities (at 0.25 s and 0.75 s)
are slightly higher for the CPP group but with no significance. Average velocities at the
same timesteps for the concentric occluded state control and CPP groups showed that
lower velocities were slightly higher for the CPP group but without a significant difference
(Fig. 4-6B). On the other hand, the peak velocities for the CPP group showed a significant
increase in velocity (p<0.05). Average velocities at the same timesteps for the eccentric
occluded state control and CPP groups are shown in Figure 4-6C. peak velocities were
slightly higher for the CPP group compared to the normal group but without any significant
difference. The peak velocities for the CPP group compared to the normal group were
higher with no significant difference in velocity. A comparison of the absolute mean peak
velocity differences of the normal and occluded states is shown in Figure 4-6D. The absolute mean peak velocity difference is 0.00667 m/s for the normal state, 0.0300 m/s for
the eccentric occluded state and 0.0879 m/s for the concentric occluded state. These
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results suggest that CPP-induced calcification of arterial walls plays a role in increasing
blood flow velocities at the site of occlusion.
The Reynolds number describes the flow pattern, with lower numbers indicating
laminar flow and higher numbers indicating turbulent flow. The Reynolds number for the
normal and occluded states were evaluated (Fig. 4-6E). Results of the Reynolds number
versus time analysis showed that there was little to no difference in the Reynolds number

Figure 4-7. Surface pressure along the BEBV and silicone tubes versus time, at 0.25s, and 0.5s.
Simulation images of the pressure of the control (A) and CPP (B) BEBV under normal conditions.
Simulation images of the pressure of the control (C) and CPP (D) BEBV when a 75% concentric occlusion is present displaying a significant increase in pressure before and at the plaque during timestep
0.25s. Pressure simulation images of the control (E) and CPP (F) BEBV when a 75% eccentric occlusion is present, also showing a significant increase in pressure before and at the occluded region.
(Scalebar = 20 mm) (Pinnock et al., 2020)
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at the peak timesteps for both groups in the normal state. In contrast, for the occluded

Figure 4-8. Description on next page.
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Figure 4-8. Is a graph comparing the average total pressure of the normal control (solid blue) and
CPP (dashed orange) BEBVs with respect to time (A). The average total pressures of the concentric
occlusion condition comparing the control (sold blue) and CPP (dashed orange) groups with respect
to time (B). A significant increase in pressure was observed in the peak timesteps for the CPP group
compared to the control. The average total pressure of the eccentric occlusion condition comparing
the control (solid blue) and CPP (dashed orange) BEBVs groups with respect to time (C). A significant
increase in pressure was observed in the peak timesteps for the CPP group compared to the control.
A bar graph comparing the absolute mean pressure difference of the average at maximum time points
for the normal and occluded conditions to further observe the difference between the control and
CPP groups (D). Graph comparing the wall shear stress of the control and CPP BEBV groups at
different times under normal (E), eccentric occlusion conditions (F) and concentric occlusion conditions (G). A significant increase in shear stress in present in all conditions at all timesteps. (** p<0.01,
***p<0.001) (Pinnock et al., 2020)

states, there was an increase in the Reynolds number for the CPP group compared to
the control group at the peak timesteps, with the concentric occlusion group displaying
the largest Reynolds number. The Reynolds number for the normal and occluded states
describe a flow that is laminar. Due to the increase in velocity at the site of occlusion, the
Reynolds number has increased showing that the flow will transition into turbulent flow as
the plaque grows and the vessel wall further stiffen. This analysis shows that CPP calcification increases the Reynolds number in the presence of an occlusion.
Simulated bioreactor blood pressure results are displayed in Figure 4-7. The normal state control and CPP group pressure gradient along the length of the modeled bioreactor setup were observed at timesteps 0.25 s, and 0.5 s (Fig. 4-7A and B). Both
groups showed an increase in pressure inside the BEBV and silicone tubes at the peak
timestep of 0.25 s where pressure was maximized. At the lower timestep of 0.5 s, the
pressure was minimized. For the concentric occlusion state control and CPP groups, a
significant increase in pressure at and before the modeled occlusion site during the peak
timestep at 0.25 s was observed, with the concentric occluded CPP BEBV model displaying the highest pressures (Fig. 4-7C and D). Lower pressures are seen at timestep 0.5 s
for both concentric occluded states. For the eccentric occlusion state control and CPP
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groups, a significant increase in pressure before and at the occlusion site during the peak
timestep at 0.25 s was observed, with the eccentric occluded CPP BEBV model displaying the highest pressures (Fig. 4-7E and F).
The average pressure values at timesteps 0.25 s, 0.5 s, 0.75 s and 1 s for the
normal state control and CPP group are shown in Figure 4-8A. Minimum pressures (at
0.5 s and 1 s) were similar with no significant difference between the groups. Peak pressures (at 0.25 s and 0.75 s) also were similar with no significance. Concentric occluded
state pressures displayed no significant difference between the groups for lower pressures (Fig. 4-8B). For peak pressures in the concentric occluded state, the CPP group
displayed a significant increase in pressure compared to the control group (p<0.01). For
the eccentric occluded state control and CPP groups, lower pressures appeared similar
with no significant difference between the groups (Fig. 4-8C). On the other hand, the peak
pressures for the CPP group displayed a significant increase in pressure compared to the
control group (p<0.001). The absolute mean peak pressure difference was 0.253 Pa for
the normal state, 37.5 Pa for the concentric occluded state and 24.7 Pa for the eccentric
occluded state (Fig. 4-8D). These results show that CPP calcification of the arterial vessel
wall increases the fluid (i.e. blood) internal pressure before and at the occlusion site for
both concentric and eccentric plaque formations.
The average wall shear stress was analyzed of the normal state control and CPP
BEBV at the center of the vessels as mounted in the bioreactor setup (Fig. 4-8E). The
wall shear stress for the CPP group was significantly higher than the control group across
all timesteps (p<0.001). The wall shear stress was significantly higher in the CPP group
across all timesteps compared to the control group in both the concentric (p < 0.001) and
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eccentric (p < 0.01) states (Fig. 4-8F and G). These results show that CPP-induced cal-

Figure 4-9. Description on next page.
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Figure 4-9. Total Deformation of a longitudinal section of the control (A) and CPP (B) of the BEBV
under normal conditions, control (C) and CPP (D) of the BEBV under concentric occlusion conditions,
and control (E) and CPP (F) of the BEBV under eccentric occlusion conditions. Comparison of the
average deformation of control (blue) and CPPs (orange) groups over each time step under normal,
concentric and eccentric conditions (G). Results show 0.653 ± 0.0405 mm (normal control), 0.530 ±
0.0366 mm (normal CPP), 0.519 ± 0.139 mm (concentric control), 0.484 ± 0.153 mm (concentric
CPP), 0.498 ± 0.0750 mm (eccentric control) and 0.462 ± 0.0790 mm (eccentric CPP). Comparison
of the average strain over each time step of control (blue) and CPP (orange) groups over each time
step under normal, concentric and eccentric conditions (H). Results show 0.254 ± 0.0140 mm/mm
(normal control), 0.217 ± 0.0100 mm/mm (normal CPP), 0.326 ± 0.0760 mm/mm (concentric control),
0.306 ± 0.0790 mm/mm (concentric CPP), 0.334 ± 0.0240 mm/mm (eccentric control), and 0.308 ±
0.0280 mm/mm (eccentric CPP). Comparison of the average stress over each time step of control
(blue) and CPP (orange) groups over each time step under normal, concentric and eccentric conditions (I). Results show 1760 ± 129 Pa (normal control), 1740 ± 126 Pa (normal CPP), 1787 ± 345 Pa
(concentric control), 1840 ± 388 Pa (concentric CPP), 1660 ± 208 Pa (eccentric control) and 1690 ±
234 Pa (eccentric CPP). (Scalebar = 20 mm, ** p<0.01, ***p<0.001) (Pinnock et al., 2020)

cification affected the tangential stress of the blood flow at the vessel walls.
Computer Simulated BEBV Vessel Wall Mechanics
Vessel wall deformation for normal, concentric occluded and eccentric occluded
state BEBVs were evaluated in the simulation (Fig. 4-9G). Average deformation over
timesteps from 0.05 s through 1 s in 0.05 s increments was evaluated. The normal state
had an average deformation of 0.653 ± 0.0405 mm for the control group and 0.530 ±
0.0366 for the CPP group. Interestingly, the CPP group displayed a significant decrease
in the average deformation compared to the control group (p<0.001). The concentric occluded state had an average deformation of 0.519 ± 0.139 mm for the control group and
0.484 ± 0.153 mm for the CPP group. There was a slight decrease in the CPP group
compared to the control group although with no significance. The eccentric occluded state
had an average deformation of 0.498 ± 0.0750 mm for the control group and 0.462 ±
0.0790 for the CPP group. There also was a slight decrease in the CPP group compared
to the control group but with no significance. These results suggest, similarly to the tensile
data, that CPP induction lowers the compliancy with a greater significance when plaques
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are not present. When plaques are present compliancy is already impacted by the thickening of the vessel walls but the addition of CPPs still slightly stiffens in the occluded
states.
The vessel wall strain for normal, concentric occluded and eccentric occluded state
BEBVs were evaluated in the simulation (Fig. 4-9H). Average strain over timesteps from
0.05 s through 1 s in 0.05 s increments was evaluated. The normal state had an average
strain values of 0.254 ± 0.0140 mm/mm for the control group and 0.217 ± 0.0100 mm/mm
for the CPP group (Fig. 9H), representing a significant decrease in the CPP group compared to the control group (p<0.001). These results suggest, similarly to the tensile data,
that the CPPs lowered the compliancy of the BEBVs due to calcification of the vessel
wall. The concentric occluded state had an average strain of 0.326 ± 0.0760 mm/mm for
the control group and 0.306 ± 0.0790 mm/mm for the CPP group. There was a slight
decrease in strain in the CPP group compared to the control group although with no significant difference. The eccentric occluded state had an average strain of 0.334 ± 0.0240
mm/mm for the control group and 0.308 ± 0.0280 mm/mm for the CPP group. Similar to
the normal state, there is a significant decrease in the CPP group compared to the control
group (p<0.01). These results suggest that the increase in pressure before and at the
occlusion sites for both concentric and eccentric plaque formation is increasing the strain
the vessel wall experiences.
Vessel wall stress for normal, concentric occluded and eccentric occluded state
BEBVs were evaluated in the simulation (Fig. 9I). Average stress over timesteps from
0.05 s through 1 s in 0.05 s increments was evaluated. The normal state had an average
stress of 1760 ± 129 Pa for the control group and 1740 ± 126 Pa for the CPP group, with
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no significant difference between the groups. The concentric occluded state had an average stress of 1787 ± 345 Pa for the control group and 1840 ± 388 Pa for the CPP group.
The values for the CPP group were slightly increased compared to that of the control but
with no significance. The eccentric occluded state had an average stress of 1660 ± 208

Figure 4-10. Tensile force comparison graph (A) comparing the engineered disease media (EDM)
ring (grey) to the control (blue) and CPP (orange) ring tensile data present in Figure. 4-2. Stressstrain comparison graphs comparing the EDM to control and CPP rings (B). Bar graphs are presented
comparing the elastic modulus (C), ultimate tensile strength (D), failure strain (E), and stiffness (F) of
the EDM rings to the control and CPP rings. (* p<0.05, ** p<0.01, *** p<0.001)

84

L

L

L

Figure 4-11. An image of an EDM ring in culture (A). H&E stain of the EDM ring at
4x (B). Von Kossa stain was performed to visualize the CPPs embedded inside of
the hydrogel at 4x (C). A close up 10x image shows CPPs (black arrows) in abundance in the hydrogel (D). ox-LDLs embedded in the hydrogel were visualized via Oil
Red O stain at 4x (E). A 20x image focused on a monocyte (black arrow) that has
engulfed some ox-LDL that in the hydrogel (F). (4x Scalebar = 1000 µm, 10x Scalebar = 400 µm, 20x Scalebar = 200 µm)

Pa for the control group and 1690 ± 234 Pa for the CPP group. Average stress value for
the CPP group was slightly increased compared to the control but with no significance.
These results show that the addition of CPPs to induce calcification to a concentrically
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and eccentrically occluded vessels results in a significant increase in pressure, leading to
an increase in stress on the arterial wall.
Tensile Mechanics of the Engineered Disease Media ring
EDM ring tensile mechanics were compared to the control rings and CPP rings
reported on earlier in the chapter. Tensile force comparison graphs are shown in the in
Figure. 4-10A, where the EDM had average peak force of about of 91 ± 27 mN. A stressstrain comparison of is shown where tensile properties are seen to differ from that of the
control and CPP rings (Fig. 4-10B). The EDM ring had an elastic modulus of 16.9 ± 3.6
kPa (Fig. 4-10C), which was significantly higher (p < 0.001) than that of the control ring.
Observing the other tensile properties, the EDM had ultimate tensile strength of 29.0 ±
6.55 kPa (Fig. 4-10D), a failure strain of 324 ± 25.3 % (Fig. 4-10E) and a stiffness of 6.88
± 1.60 N/m (Fig. 4-10F). All these values were significantly different (p < 0.05) from the
control group showing a change in mechanical properties due to the macrophages, oxLDL and CPPs present in the tissues. On the other hand, these values were not significantly different from the CPP group.
Engineered Disease Media Ring Histology
Figure 4-11A shows an image of an EDM ring that has successfully rolled in towards the post, forming a stable tissue. An H&E stain was performed on the EDM ring to
determine whether cells were still present in the tissue (Fig. 4-11B). Following this a Von
Kossa stain was conducted to probe for the presence of the CPPs (Fig. 4-11C and D).
The CPPs stained brown black (black arrows), due to exposure of silver nitrate to UV light
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Figure 4-12. Natural disease (ND) vessel (A) and ND vessel after static rotational macrophage seed
(B). Oil Red O stain at 4x is presented (C) alongside a 40x close up of the same region to observe a
macrophage that has migrated into the media layer and engulfed an ox-LDL particle (black arrow) (D).
A hole in the sample created by macrophage migrating and engulfing the ox-LDL in the fibrin gel (E).
An observation of the red ox-LDL particle with cells that appear to be macrophages in the same region
(black arrow) (F). The same region at 40x show the macrophages engulfing the ox-LDL that was most
likely in place of the hole prior to macrophage migration (G and H). (4x Scalebar = 1000 µm, 10x
Scalebar = 400 µm, 40x Scalebar = 100 µm)

during a step in the staining process and can be observed embedded in the hydrogel. An
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Oil Red O stain was performed (Fig. 4-11E) the hydrogel stained red due to the abun-
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Figure 4-13. Von Kossa stain of natural disease (ND) at 20x after static rotational macrophage
seeding. Presence of CPPs present in the lumen of the ND vessel (black arrow) (A). Calcium
deposits can be seen in the hydrogel and in the extracellular matrix of the smooth muscle cells
(black arrows) (B-D). (20x Scalebar = 200 µm)

dance of ox-LDLs embedded inside. Figure 4-11F is a close up of a THP-1 monocyte
that has some ox-LDLs that were present in the hydrogel (black arrow). This assumed
because a part of cell stained red and only lipids stain that color in this method.
Early Stage In Vitro Atherosclerosis Disease Model with Natural Disease BEBV
Figure 4-12A shows a ND vessel composed of smoot muscles cells, fibrin hydrogel and ox-LDLs. Following the static seeding of M1 macrophages the lumen of the vessel
remained open and vessel appeared to still have structural integrity (Fig. 4-12B). The ND
BEBV was frozen down in optimal cutting temperature (OCT) compound and cryo-sectioned. Following sectioning the samples were fixed in 2% formalin solution and stained
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via Oil Red O solution with a hematoxylin counter stain for the nuclei. The Oil Red O stain
was used to visualize the ox-LDLs and macrophages in the tissue rings (Fig. 4-12C). The
presence of the macrophages was determined similarly via the observation of red ox-LDL
particles that appear inside of the cells (black arrow) (Fig. 4-12D). In Figure 4-12E we
noticed what appeared to be a hole in the lumen fibrin gel with cells that appear to be
going inside of the layer containing the SMCs. Looking further in the region we noticed
cells huddled around a red particle (Fig. 4-12F). In the 40x we noticed that this particle
ox-LLD due to the red stain (Fig. 4-12G). These cells are probably the initial macrophages
that migrated into the region via engulfing the ox-LDLs in the fibrin hydrogel. This explains
the hole in the sample with the trail of cells which probably macrophages as well. Cells
closer to the opening of the hole also appear to have red ox-LDL particles inside them
confirming that are too macrophages that migrated via the engulfing the opening (Fig. 412H).
Figure 4-13 shows a von Kossa staining of the ND engineered vessel at 20x magnification. The presence of the CPPs are seen in the lumen of the engineered vessel
(black arrows) (Fig. 4-13A). In Figure 4-13B-C the presence of the extracellular calcium
is seen in the hydrogel and media layer of the vessel. This shows that the presence of
the CPPs in the lumen of the engineered vessel induces smooth muscle cell secretion of
calcium in the extra cellular matrix of the tissues (black arrows).
Discussion
In this work, we have shown the efficacy of augmenting a tissue engineered calcification model of atherosclerosis using a 3-dimensional computer simulation to better understand the effects on the hemodynamics of the system. Importantly, this approach was
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effective in evaluating the distinctly different occlusion geometries present in atherosclerosis, which are challenging to replicate consistently in existing models. As with all computer models, input of experimental data is ideal for optimizing simulations. This process
can be counterintuitive as computer models are touted as a substitution for experimental
methods although experimental data is still needed. In actuality, the combination of both
methods is the optimum approach.
In the present study, we reported for the first time the successful use of CPPs in a 3dimensonal cylindrical cell culture tissue model to induce atherosclerotic calcification.
Other past studies have used CPPs in vitro but only in 2-dimensional cell culture, thus
providing limited scientific information. The ability to create a BEBV in our lab and our
capabilities to generate computer simulations gave us the unique position of being able
to mechanically, hemodynamically and computationally evaluate our tissue engineered
atherosclerotic calcification model. With our unique combination of in vitro and computational modelling, the effects of calcification can be better understood.
Tensile data showed an increase in stiffness via calculation of the elastic modulus for
CPP rings when compared to rings without CPPs. This trend continues when observing
the tensile data for the BEBVs the elastic modulus increases significantly when compared
to the control tissues. The atherosclerotic human CIA tensile data showed a larger elastic
modulus, when compared to normal human CIA, even though it had a significantly lower
ultimate tensile strength. Tissue were only stretched circumferentially and not longitudinal
due to the lack of the abundance of human normal and atherosclerotic blood vessels,
therefore it made sense to only use uniaxial data for the purpose of this study.
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The human CIAs obtained have a low number of samples because of the lack of
clinical availability. However, we were fortunate to obtain the CIA samples. The tensile
mechanics of the human CIAs proved that stiffening due to atherosclerotic calcification
overtime leads to vessels that have a higher elastic modulus when compared to their
normal counterparts. Using the measured elastic modulus form the tensile data presented, a ratio can be determined from the atherosclerotic CIA divided by the normal CIA
providing a value of 1.55. This value was used to measure the relative stiffness of the
engineered model to the actual human CIA. The ratio was 1.96 for the singular rings and
1.33 for the BEBVs. According to this comparison the singular rings did in fact have a
higher relative stiffness when compared to the human arteries. One problem that could
be brought to attention is that the singular rings are not in a tube-like cylindrical form as
the human arteries are. The BEBV ratio is about 85% that of the human artery ratio and
is probably not as high as the singular rings due to the cumulative effect the rings have
when in vessel form. Instead for failing at a lower strain rate like the CPP singular rings,
the CPP BEBVs failed at a higher strain rate. This further proves how forming the rings
into vessels increases the overall toughness of the tissues. The results from the tensile
mechanics provide some evidence that confirms previous studies conclusions on CPPs
inducing SMC extracellular calcium secretion.
Using CPPs to create an in vitro atherosclerotic disease model was validated with a
bioreactor-based computer simulation using ANSYS 19. ANSYS provided a powerful
CFD (Fluent) and Mechanical (Transient Structural) coupled plate platform if there is experimental uniaxial data. It was determined that the fluid velocity and pressure increased
in the CPP BEBV occluded state. These data suggest that CPPs circulating in the blood
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in CKD patients could be lowering the compliancy of the vessel wall of their arteries [24].
It is interesting to note that when an occlusion is present that the hemodynamic differences become more apparent. On the mechanical perspective, the CPP BEBV normal
state displayed a lower deformation then that of the control BEBV. However, the CPP
BEBV occluded state only displayed a slightly lower deformation. This could be due to
the increased fluid velocity and pressure inside of the CPP occluded state due to the
obstruction. The blood appeared to pool before the occlusion, and the pressure built further expanding the vessel. This occurred because of the increased stiffness of the vessel
walls causing a loss of compliancy allowing the pressure to increase. Also, the tissues
reluctance to expand further resulted in increased fluid velocities at the site of the occlusion. Most notably is the increase in the Reynolds number of the CPP BEBV occluded
states compared to that of the control BEBV occluded states, indicating movement towards turbulent flow due to the occlusions. Although the flow remained laminar, the addition of CPPs to stiffen the vessel walls brought the fluid flow increasing the potential for
turbulent low. It is possible that at a higher concentration of CPPs, the vessel walls could
further stiffen, leading to a complete transition to turbulent state.
The concentric and eccentric occlusions were modelled with geometries that approximated occlusions observed in the body due to the limitations inside of the Fluent toolbox
within ANSYS 19 when using a 3-dimensional model. We were only able to correctly map
the fluid boundary layers using geometries that allowed for symmetric textures when
meshing. A suggestion to create or use a more highly specialized 3D CFD software that
will account for the lack symmetry in the fluid and still properly map the boundary layers.
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EDM rings were successfully formed. Tensile analysis of the EDM ring compared to
the control and CPP rings showed the combined additions of ox-LDL, CPPs and THP-1
cells in the hydrogel change the mechanical properties of the tissue due having it own
distinctive stress-strain curve. This is also confirmed via the significant difference between
the control and EDM rings. The lack of significance between the CPP rings and the EDM
rings shows the stiffing effect of the CPPs in the engineered tissues. This is reinforced
via the string presence of the CPPs via the Von Kossa stain. The H&E stain proved that
cells a still present in the tissues. Ox-LDLs and some macrophages were visualized via
the Oil Red O stain. Not as many macrophages engulfing ox-LDL compared to the ND
BEBV due to the embedded THP-1 being undifferentiated.
ND rings and vessels were successfully formed. This engineered vessel represented
the 2-cell layer in vitro atherosclerotic disease model pertaining to the smooth muscle
cells and endothelial cells. Via an Oil Red O stain macrophage migration and ox-LDL
uptake were visualized. A number a macrophage with engulfed ox-LDLs were present
after static rotational seeding of differentiated THP-1. Macrophages appeared to have
migrated into the media layer via aggressively engulfing some of the fibrin gel containing
the ox-LDLs. Via a von Kossa stain CPPs were viewed in the lumen of the engineered
vessel. Early smooth muscle cell excretion of extracellular calcium was observed in the
hydrogel and tunica media layer of the engineered vessel.
The results from the present study suggest that CPPs can be used to potentially create a late stage atherosclerosis in vitro disease model to test vessel wall compliancy. At
the very least, the CPP approach can serve as a viable method to expedite the calcification process inside the walls of a tissue engineered model. In addition, the creation of the
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intima layer and the statically seeding macrophages proved to be a successful early stage
in vitro atherosclerotic disease model seen via the aggressive migration of the macrophages into the media layer.
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CHAPTER 5 CONCLUSIONS
To create an atherosclerosis model of vascular biomechanics, one must begin with
understanding the inflammation processes that leads to the onset of the disease. Being
able to mathematically model the system is a tool that allows for us to quantitatively take
into consideration hemodynamic flow, Reynold’s number, surface pressure of the vessel,
wall shear stress, circumferential strain, and compliance of a blood vessel. Once this is
achieved it is more efficient when trying to create an in vitro tissue engineered and computational model of the system. Which can be used to better understand specific pathology that alters the biomechanics of blood vessels. This has benefits when it comes to
testing current and new drugs prior to using animals.
By employing our novel vascular tissue engineering methodology, we could construct
a viable, customizable vessel applicable to a variety of testing and treatments developments. The cellular composition, wall thickness, and length of the vessel all carry the
potential to be scaled for any individual testing purpose. Due to the customizable nature
of this construct, it has capacity for future application in disease modeling, drug testing,
and in the study of cell–cell interaction. Our novel methods provide a highly modifiable
method for creating a durable vessel with a wide range of potential applications.
Overall, our results show that the Ring Stacking Method can be easily scaled to
achieve a range of engineered vascular tissue sizes. Scaling to the largest human vessels, such as the 40-mm lumen diameter aorta. This will enable tissue and computational
modeling validation of vessel of any size. We also were able to seed for the endothelial
cell layer (i.e. the intima) via a static and bioreactor aided dynamic method. Thus, we are
able to create a combined intima and media layer. This confirms that our vessel constructs
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can be easily coated with endothelial cells showing that it could be used as a graft or
atherosclerotic disease model. The intima is very critical for an atherosclerotic disease
model and should be looked at further in conjunction with the media layer in order to
develop an in vitro model further.
This thesis showed that computer simulations can provide insight on the development
of biologically engineered blood vessels. Through carefully mathematically modeling the
physiological and/or in vitro system the tissue will be evaluated. Biologically derived nanoparticles such as CPPs that are linked to pathology can be implemented into a 3D
tissue culture in order to collect mechanical data that can be used as a material input in
a computer simulation. With the implementation of THP-1 monocytes into the media tissue rings we set the foundation of our research into the area of the disease modeling.
The in vitro model with a media, intima and ox-LDLs in the vessel walls proved successful
when seeded with activated THP-1 cells. Aggressive macrophage migration 3-dimensionally into the vessel showed that it possible to create a simple 3D tissue engineered disease model that follows somewhat close to physiology. There is still more work to be done
in this area because the development of a fibrous cap is critical to creating a viable disease model. With the aid of the bioreactor created to seed the intima another student can
pick up where I left off and create a full tissue engineered model.
Future Directions
This body of work can potentially be improved upon later incorporating the tunica
adventitia layer. Future utilization of a combination of dynamic flow for incorporation of
the of THP-1 monocytes, ox-LDLs and CPPs, could bring further insight on the atherosclerotic disease process. Dynamically flowing more ox-LDLs and macrophages in the
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system over time could potentially lead to a formation of a fibrous cap and later calcified
plaque formation. With this achieved one could model and learn more about the different
stages and progression of atherosclerosis without the use of an animal model. Eventually
use of this engineered vessel for disease modeling could be used as the preliminary step
in testing drug treatments and medical procedures in short-term and long-term. Researchers will be able to test their potential treatments in vitro using a human engineered vessel
before moving on to animal testing. This potentially could reduce the number of animals
tested in the medical drug development process. Even more relieving is the potential that
researchers will be able to better understand and predict the effects of these new treatments on human cells and tissues prior to clinical trials. Thus, allowing for a cheaper and
more time saving scientific iterative process.
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ABSTRACT
IN VITRO ATHEROSCLEROSIS DISEASE MODEL VIA THE RING STACKING
METHOD
by
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Degree: Doctor of Philosophy
Creation of an in vitro atherosclerotic disease model using the novel Ring Stacking
Method. Singular self-assembling tissue rings made up smooth muscle cells and fibrin
hydrogel are stacked on one another to create a tissue engineered vessel. These biologically engineered blood vessels are then seeded with endothelial cells via combined static
rotational and dynamic bioreactor in order to create a functional intima layer. Early stage
atherosclerosis was induced via the addition of oxidized low-density lipoproteins (ox-LDL)
to the fibrin hydrogel that creates the media layer of the engineered vessel. After the
creation of the intima layer the engineered vessel was then statically seeded with THP-1
monocytes differentiated into M1 macrophages via phorbol 12-myristate 13-acetate
(PMA), lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma) for 24 hours over
the course of 3 days. On the second and third day calci-protein particles (CPPs) along
with fibroblast-derived growth factor (FGF) and platelet-derived growth factor (PDGF)
were added to the THP-1 differentiation suspension. Following static macrophage seeding the engineered disease vessel was frozen, sectioned and stained via an Oil Red O
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stain to visualize the macrophage migration and uptake of the ox-LDLs in the hydrogel.
Late stage atherosclerotic calcification was characterized via the incorporation of CPPs
into engineered vessels. These vessels were mechanically tested, and the data was incorporated into a system coupled computer fluid dynamic (CFD) simulation via ANSYS
19. Engineered disease media (EDM) rings pre-seeded with smooth muscle cells, oxLDLs, undifferentiated THP-1 cells and CPPs were mechanically and histologically characterized.
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